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 Mycobacterium tuberculosis, Mtb, is a successful pathogen that secretes variety of 
proteins to manipulate the host defense mechanisms and create a proper environment for its 
survival. The progression of the disease depends on the regulated secretion of essential 
virulence factors such as culture filtrate protein-10 (CFP-10), and early secretory antigenic 
target-6 (ESAT-6). Mtb regulates the secretion of the virulence factors through interactions of 
MycP1 protease with EspB (Early secretory protein B) protein.  
  One of the goals of this thesis was to provide the first crystal structure of EspB protein 
in order to gain insight into the expression, secretion, function and transmembrane 
translocation of this protein. EspB292 (residue 1-292) structure has 16 monomers in the 
asymmetric unit that are arranged into a set of four homotetramers. To clarify the components 
that affect oligomerization of the EspB292 in the biologically relevant conditions, we set up 
experiments that mimic the phagosomal environment.  
 
 In addition to work done on EspB protein, structural determination of atypical 
Chaetomium thermophilum Ct-Rio2 in presence of transition state analogs such as sodium 
orthovanadate and beryllium fluoride is reported to define the importance of individual 
domains in binding ATP. Rio2 is required for site D cleavage and maturation of the small 
subunit ribosomal RNA (rRNA). In this study, the structures of the Ct-Rio2 and its binding to 
ADP/BeF2 and ADP/VO42- are investigated. The structure are expected to mimic the transition 
state of the phosphoryl transfer from ATP to Asp257 in Rio2’s active site and the subsequent 
hydrolysis of the aspartyl phosphate that could power late cytoplasmic 40S subunit 
biogenesis. 
 Collaborative work on the structural characterization of the G228 Ct-Rio2 mutant 
protein is also reported. Our goal is to investigate the evolutionary relationship between Rio 
kinases and the canonical eukaryotic protein kinases. Our hypothesis is that canonical 
eukaryotic protein kinases have evolved from Rio kinases. We have made several mutations 
in a key differentiating position of the kinase domain sequence of Ct-Rio2, G228, and have 
collected biochemical data to test the ability of the mutated Rio kinase to autophosphorylate 
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 During my PhD program, I have worked in two labs. During my time in Prof. Jeffery 
T. Davis lab, I started the study of the amphiphilic natural products for the purpose of anion 
transport across the lipid bilayer of the membrane. For information on this project the reader 
is referred to the following research article.  
Bahmanjah, S., Zhang, N., Davis, J. T. Monoacylglycerols as transmembrane Cl− anion 
transporters. Chem. Commun. 2012, 48, 4432-4434. 
  In Dr. Nicole LaRonde’s lab, I worked on three main projects that are described in 
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Figure 4.6 Alignment between bound AMP to CtRio2 at both pH 5.2 and pH 7.0: The 
structures of Ct-Rio2 are aligned based on the AMP location. The orientation of Asp 257 is 
the same for both of the crystals.  
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D232 are indicated by arrows. The cartoon representation was made by PYMOL. 
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Figure 5.2 Crystal Structure of AMP bound Ct-Rio2: The N-terminus of Ct-Rio2 contains 
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Figure 6.4 Crystal Structure of AMP-bound G228N: The crystal structure of Ct-Rio2 with 
Asn mutation at residues 228 shows a bilobal kinase domain (blue and yellow) connected to 
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117 
Figure 6.6 The overlay of the C-Terminal domain in the crystal structures of G228N 
and G228G (wild type Ct-Rio2): The winged helix domains of the two structures are not 
completely superimposable. The presence of Asn in the structure pushes the winged helix 
domain to provide a larger phosphate binding loop. 
 
118 
Figure 6.7 The overlay of the AMP domain in the crystal structures of G228N and 
G228G (wild type Ct-Rio2): The N and C terminal lobes of the two structures are not 
completely superimposed. The presence of Asn in the structure pushes the winged helix 
domain back to provide a larger phosphate binding loop. 
 
119 
Figure 6.8 The overlay of the C-Terminal domain in the crystal structures of G228N, 
G228A and G228G (wild type Ct-Rio2): The winged helix domain of the G228A and G228 
are very close to each other compared to the G228N. The presence of Asn in the structure 
seems to push the winged helix domain back to provide a larger phosphate binding loop. 
 
120 
Figure 6.9 The proteins with different point mutations at 228, show very different 
activities in their A) ATPase and B) Auto-phosphorylation experiments: The G228A and 
Ct-Rio2 with G228 are similarly active in the hydrolysis of ATP but mutant’s residues such 


































    
A Alanine 
Å Angstrom  
ADP Adenosine-5’-diphosphate 
APS Advanced Photon Source 
ATP  Adenosine-5’-triphosphate 
BME  β-mercaptoethanol 
C Cysteine 
CFP-10 culture filtrate protein-10 
COOT Crystallographic Object Oriented Toolkit 
Ct-Rio2  Chaetomium thermophilum Rio2 
D Aspartic Acid 
Da Dalton 
°C Degrees Celsius 
ClC Chloride Channel 
CGV Calmette-Guérin vaccine 
DNA Deoxyribonucleic Acid 
E Glutamic Acid 
EDTA Ethylenediaminetetraacetic Acid 
ePKs Eukaryotic Protein Kinases 
ESAT-6 early secretory antigenic target-6 
EspA early secretory protein A 
EspB Early secretory protein B 
EspC early secretory protein C 
ESX-1 early secretory export type I 
F Phenylalanine 
FPLC Fast Protein Liquid Chromatography 







HIV human immunodeficiency virus  
HYSS hybrid substructure search 







MAD Multiple Wavelength Anomalous Diffraction 
MDR-TB multiple drug-resistant tuberculosis  
Mg Milligram 
MgCl2 Magnesium Chloride 
Mg2+ Magnesium ion 
mL Milliliter 
mM Millimolar 
Mtb Mycobacterium tuberculosis 
MycP1 Mycobacterium Protease 1 
N Asparagine 
NECAT Northeastern Collaborative Access Team 
P Proline 
PCR Polymerase Chain Reaction 
PEG Polyethylene Glycol 
PHENIX Python-based Hierarchical Environment for Integrated Xtallography 
Q Glutamine 
R Arginine 
RB Ribosome Biogenesis 
RD1 region of difference 1 
RMSD Root Mean Square Deviation 
RNA Ribonucleic Acid 






S Svedburg Unit 
SAD Single Wavelength Anomalous Diffraction 
SeMet Selenomethionine 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SSU Small Ribosomal Subunit 
T Threonine 
T7SS Type VII secretion system 
TAP Tandem Affinity Purification 
TB tubercle bacillus 
TEV Tobacco Etch Virus 





wHTH Winged Helix Domain 
Y Tyrosine 









Chapter 1: Introduction 
 In this study, X-ray crystallography is utilized as a form of high resolution microscopy to 
visualize protein structures at the atomic level. Using the three dimensional structure of a protein, 
we have obtained insight into the function and mechanism of our target proteins. Armed with this 
information that is presented in the following chapters, our ultimate goal is to design novel drugs 
or inhibitors that target a particular enzyme or rationally engineering an enzyme for a specific 
industrial process. To reach these ultimate goals, the interest of my thesis is the structural 
determination of two classes of proteins so-called EspB and Rio kinase protein. 
 The diffraction from a single molecule would be too weak to be measurable. So, we use 
an ordered three-dimensional array of molecules, in other words a crystal, to magnify the signal. 
Even a small protein crystal might contain a billion molecules. If the crystal is well ordered, then 
diffraction will be measurable at high angles and resolution and a detailed structure should result. 
Hence, to obtain structural information about a particular protein, essentially a pure sample of the 
target protein is required. 
 We can do this either by isolating the protein from a source, or by cloning its gene into a 
high expression system and purifying the protein. Following the later process, EspB and Rio2 
family of proteins are purified. The pure and homogeneous samples of the proteins have been 
further used to be crystalized using the hanging drop crystallization method. Our structural 
observations have provided us with insight into how our target proteins interact with other 
molecules or one another, how they undergo conformational changes, and how they perform 
catalysis in the case of Rio kinases. 
 The first half of this dissertation, chapters 2 and 3, involves the structure determination of 




the crystal structure of EspB has been an important key to understand the function of the early 
secretory protein B in the Mtb progression.  
 In an additional work, in chapters 4-6, we were interested in structure determination of 
Ct-Rio2 family of proteins. 
 1.1 Tuberculosis Causes, Symptoms and Diagnosis  
 Tuberculosis1, or TB (short for tubercle bacillus), is a contagious disease that attacks the 
respiratory system. In the past TB was called phthisis, phthisis pulmonalis, or consumption. This 
disease is caused by Mycobacterium tuberculosis (Mtb) (Figure 1.1). Mycobacterium 
tuberculosis (Mtb) was first discovered in 1882 by Robert Koch. Tuberculosis generally attacks 
the lungs and less commonly affects other parts of the body2. Mtb spreads through the air when 
people who have an active TB infection transmit their respiratory fluids in the air by coughing, 
or sneezing3. Most infections do not have symptoms which are known as latent tuberculosis. 
However, about one in ten latent infections eventually progresses to active disease which, if left 
untreated, kills more than 50% of those infected4. The classic symptoms of active TB infection 
are chronic cough with bloody sputum, fever, night sweats, and weight loss.  
Diagnosis of active TB relies on chest x-rays and radiology, as well as microscopic 
examination of body fluids5. Diagnosis of latent TB relies on the tuberculin skin test (TST) or 
blood tests (Figure 1.1). In 2014, 8.7 million chronic cases of TB were reported, leading to 1.4 
million deaths. Geographically, the burden of TB is highest in Asia and Africa. India and China 
together define 40% of the world’s TB and Africa has 24% of the world’s TB infections4 (Figure 
1.2). Treatment of TB requires usage of multiple antibiotics over a long period of time. Social 
contacts are also limited during treatment. One of the main problems of TB treatment is the 




always better than treatment. Therefore, vaccination with the bacillus Calmette-Guérin vaccine 
(CGV) is often required in early ages to prevent the development of TB6.    
Infection of TB starts via the inhalation of the contaminated droplet. Ingestion of the Mtb 
organisms by macrophages and its multiplication within macrophages leads to the inflammatory 
responses. The TB can further develop to a more severe disease by the extension of organisms 
into the bloodstream followed by the hypersensitivity reaction (Figure 1.3). Upon Mtb infection, 
a phagosome is formed via phagocytosis of the bacterium by macrophages7. The phagosome 
undergoes maturation by first fusing with various endosomes via the endocytic pathway followed 
by fusion with lysosomes to form phagolysosomes. During phagolysosome formation, 
degradative enzymes that destroy invading pathogens are released and the pH drops to about 4.5. 
This pH provides an environment that is not conducive for Mtb survival. This process, 
phagolysosome formation, is one of the multiple antimicrobial responses that the host cell 
employs to limit the growth of infection8. 
 1.2 Tuberculosis Virulence Mechanism  
 Remarkable capacity of Mtb to infect, and manipulate variety of host defense 
environments has turned tuberculosis to the world’s leading infectious disease after HIV, causing 
two million deaths every year4. Survival of Mtb in macrophages is critical to the virulence and 
pathogenesis of the bacterium. One survival response that Mtb utilizes in inhibition of 
phagosome maturation is prevention of acidification of the phagosome by lysosomes to pH of 
about 4.5. The phagosome is hence, arrested in the endocytic pathway under a promotive pH of 
about 6.4 and therefore, phagolysosomes are not formed9.  
 The phagosome inhibition mechanism is not well understood but studies do show another 




1. This secretion pathway aids Mtb to manipulate its environment by delivering virulence factors 
during infection10. The secretion of variety of proteins that evade, modulate and control host 
immune responses creates a favorable environment for its intracellular survival and replication of 
Mtb. Since Mycobacteria have highly protective, and hydrophobic waxy coating of mycolic 
acids known as the mycomembrane11, the export of the virulence factors, either to the 
extracellular environment or directly in the host cell, requires a special system that is known as 
the ESX or type VII secretion (T7S) pathway (Figure 1.4). Type VII secretion system (T7SS) 
has first been identified in the pathogenic organism Mycobacterium tuberculosis H37Rv and the 
corresponding gene clusters11. The T7SS follows a pairwise dependency of proteins for both 
secretion and function.  
The secreted proteins such as culture filtrate protein-10 (CFP-10), and early secretory 
antigenic target-6 (ESAT-6) that are essential for the virulence of Mycobacteria in T7SS are 
encoded by genes of RD1 (region of difference 1) and extended regions (Figure 1.5). Therefore, 
the deletion of RD1 region attenuates the virulence of TB significantly12. This region contains 
genes encoding ATP dependent motors, a number of transmembrane proteins, a protease 
(MycP1) and secretory proteins such as CFP-10, ESAT-6, EspA, EspB, EspC, and EspR that are 
prominent targets of the immune system in humans infected with Mtb13. Based on the analysis of 
RD1 components, previous studies have proposed the following models for the translocation of 
proteins (Figure 1.6). 
 The phagosomal signals initialize the transcription and secretion of two pairs EspA/EspC 
and CFP-10/ESAT-614. Once expressed, Rv3868 assembles these pairs into multimers that are 
subsequently recognized by Rv3871 and Rv387015. These two FtsK family proteins form a 




pore facilitates the ATP-dependent translocation of the substrates through the inner membrane 
pore protein (Rv3877)16. Thereafter, the interaction of the N-terminal gate-like domain of 
Rv3877 with MycP1, a serine protease, opens the pore enabling translocation of the substrate 
assembly from cytoplasm to the periplasm-like space17. Ultimately, the substrate assembly 
crosses the mycomembrane through a channel formed by Rv3869, Rv3882c and the four proteins 
of MCE cluster 1 (Mce1B, Mce1C, Mce1F and Rv0177).   
1.3 Mtb Virulence Factors 
 Various activities have been ascribed to the ESX-1 substrates ESAT-6 and CFP-10, 
including inhibition of phagosome maturation and cytokine signaling by infected macrophages, 
interaction with the macrophage immune receptor TLR and inhibition of TLR signaling and 
formation of pores in mycobacterial phagosome, perhaps allowing bacterial spread18. To perform 
the attributed activities, ESAT-6 and CFP-10 secretion is finely tuned by the interactions of 
MycP1 and Rv3881c (Early secretory protein B, EspB).  
1.4 Mtb MycP1 and EspB Proteins 
MycP1 plays a dual role in regulating the secretion activity of ESX-119. Whereas the 
MycP1 interaction with Rv3877 opens the pore to enable protein secretion, its protease activity 
negatively regulates secretion via Rv3881c (EspB) to balance the virulence and maintain the 
long-term Mtb infection20. 
1.5 Early Secretory Protein B  
 Rv3881c (Early secretory protein B, EspB) is a conserved alanine- and glycine-rich 
protein that is necessary for inhibiting phagosome maturation21. The translocation of EspB 
through the membrane involves the same machinery used by the other secretory proteins (CFP-




10/ESAT-6 through Rv3877 to the periplasm-like space. Subsequently, MycP1 cleaves EspB and 
disrupts the EspB/Rv3879c pair, resulting in the secretion of EspB. The protein MycP1 cleaves 
EspB at two sites, Ala358 and Ala386 on the C-terminus22.  
 1.6 Objectives of Structure Determination of EspB  
 The T7SS and the ESX-1 secretion pathway is not fully understood and some unknowns 
that interest my current research include: 
 The molecular structure of EspB  
 How do EspB monomers interact with one another? 
 How does EspB oligomeric state in the crystal relate to its biological functions? 
 How does the structure provide insight into cellular environments that Mtb encounters?  
 How does the structure of EspB predict the interaction with virulence factors? 
 How does the structural information predict the EspB membrane transport mechanism? 
In the chapters 2 and 3, I will describe the work that went towards structural 
determination of EspB and presents the first crystal structure of EspB along with structural 
analysis.  
In chapter two of this dissertation, the purification and crystallization procedure of EspB 
is explained in detail. We optimized purification of EspB to obtain highly pure protein samples 
that were immediately used for crystallization. In chapter two, we provide the first crystal 
structure of residues 1-292 of (EspB292) protein (which is an elastase stable fragment of full 
length EspB) and in chapter three the structure of EspB is summarized. Our findings suggest that 
this protein has 16 monomers in the asymmetric unit that is arranged into a set of four homo-
tetramers and therefore, it forms high order tetrameric aggregations upon cleavage at the 




the regulation of virulence factor’s secretion, we studied the phagosomal environmental 
conditions to investigate the elements that would impact the oligomerization of EspB.  
 In the second half of this dissertation, chapters 4-6, as mentioned earlier, we were 
interested in structure determination of Ct-Rio2 family of proteins. The structural information 
helps us understand the mechanism of phosphoryl transfer from ATP to these kinases and obtain 
evolutionary information about the relationship between the Rio family kinases and eukaryotic 
protein kinases.  
 1.7 Ribosome Structure and Function 
 Rio2 is a serine kinase that is involved in the processing of 20S pre-rRNA during the 
maturation of ribosome23. The actual role of them in the Ribosome biogenesis (RB) is not clear 
yet but recently, we have obtained many interesting information about their functions24.  
 Ribosome biogenesis is the process of making ribosomes. It is an incredibly complex 
process in the cell that spends a lot of energy to provide cell with molecular machinery for 
protein production. Ribosome biogenesis is critical for cell cycle progression and cellular 
proliferation in both normal cells and cancer cells. Any misregulation in the folding and 
assembly process of involved ribosomal RNA (rRNA) or proteins in this process can lead to 
several diseases.  
 Mature ribosomes are composed of two subunits in all organisms, the large subunit 
(LSU) and the small subunit (SSU)25. In eukaryotic cells such as Saccharomyces cerevisiae (Sc) 
the LSU is consisted of three rRNAs known as 25S, 5.8S and 5S26. In prokaryotic cells such as 
Escherichia coli, there are only two rRNAs in the LSU naming 23S and 5S27. The SSU of all of 
the ribosomes have only one rRNA which is called 18S in eukaryotic cells and 16S in the 




 In any organism, all of the rRNAs are first synthesized as a single transcript29. This rRNA 
transcript will then get cleaved and processed at different sites to produce the mature rRNAs. 
During this process many ribosomal proteins assemble on the rRNA transcript to generate the 
mature ribosome. Besides ribosomal proteins and rRNAs, numerous transacting factors are 
involved in ribosome to promote the modifications, folding and processing of ribosomal 
precursors and their ordered assembly30. Many of these non-ribosomal factors are members of 
different families of enzymes including ATP-dependent RNA helicases, AAA-ATPases, 
GTPases, and kinases31. The yeast Saccharomyces cerevisiae (Sc) and a thermophilic fungus 
called Chaetomium thermophilum (Ct) are representatives of suitable eukaryotic model 
organisms to study ribosome assembly.  
 Over the past 20 years, the easy genetic, biochemical and cell biological experimental 
accessibility has enabled us to obtain significant information about the biogenesis. For example, 
the tandem affinity purification method (TAP) facilitates the isolation of numerous non-
ribosomal intermediates along the ribosomal maturation pathway, which correspond to snap 
shots of pre-ribosomal particles27. The current challenge is to identify the direct interaction 
partners of the proteins and obtain structural and functional details of the pre-ribosomal 
particles32.  
 1.8 Ribosome Biogenesis 
 The transcription of ribosomal genes and production of pre rRNA transcript in eukaryotes 
takes place in the nucleolus33. Initially, the RNA polymerase I generates a precursor rRNA (so-
called 35S pre-rRNA) that contains the sequences for the mature 18S, 5.8S, 5S and 25S rRNA 
(Figure 1.6). The 35S pre-rRNA is enclosed by external transcribed spacer (5´-ETS and 3´-ETS) 




proteins assemble on the 35S pre-rRNA and generate a 90S complex that sediment at 90S on a 
sucrose gradient34. The newly formed 90S complex is then cleaved on the 35S pre-rRNA at 
processing sites A0, A1 and A2, within the large 90S complex, to produce the pre-40S and the 
pre-60S particles29.  While the pre-40s particle is rapidly exported to the cytoplasm, the pre-60S 
particle that contains the 27SA2 pre-rRNA remains in the nucleolus and undergo a complex 
maturation pathway in the nucleoplasm and is subsequently, delivered to the cytoplasm. The pre-
40S complex contains the 20S pre-rRNA23.  
 In the cytoplasm, the major structural rearrangement that occurs on the pre-40S is the 
formation of the ribosomal “beak” structure that requires a cascade of phosphorylation and 
dephosphorylation events35. Cryo-EM and biochemical studies have revealed that the formation 
of the beak is concomitant with the release of assembly factors such as Ltv1 and Enp136 (Figure 
1.7).    
 1.9 The Involvement of Rio1 and Rio2 in 20S Pre-rRNA Modification 
 There are two assembly factors called Enp1 and Ltv1 that are shown to be required for 
the export of pre-40S complex37. The Rio2 presence and binding in the nucleus is required for 
the export and release of Enp1 and Ltv1 from pre-40S ribosome in the cytoplasm38. In the 
cytoplasm, the 20S pre-rRNA is first, methylated at the 3´ end of the 18S rRNA sequence by the 
function of Dim1 (Figure 1.8). Subsequently, the methylated rRNA is cleaved by the function of 
endonuclease Nob1 to generate mature rRNA39. For the 3´ end access of Nob1 and the cleavage 
of 20S pre-rRNA, Dim1 and a GTPase called Tsr1 are required to be released from the pre-
rRNA40.   
Based on the UV cross-linking and cDNA analysis results by David Tollervey41 and 




center and regions required for tRNA association42. Thus, Dim1 and Tsr1 prevent the pre-40S 
complex from accessing tRNA and participating in translation. Moreover, RNA assembly factors 
have shown to play an important role in regulating RNA folding events that occur during the 40S 
assembly. For Instance, the ChemModSeq analyses has recently revealed that pre-40S particles 
that contain Rio2, Tsr1, Ltv1 and Enp1 binding sites have generally more flexible particles and 
rRNA that the late pre-40S complexes that lacked these proteins43. It appears that assembly 
factors such as Ltv1 and Enp1 act as RNA chaperones that maintain a more flexible 
conformation in the pre-rRNA by delaying folding steps of the 3´ major domain. At certain 
points during the maturation pathway, these assembly factors are no longer required and they are 
released by Hrr25-phosphorylation which reduces their affinity for RNA44. 
 Several evidences have indicated that Enp1 and Ltv1 play an important role in recruiting 
Rps3, Rps15 and Rps2031. Shortly after the release of Enp1 and Ltv1 the Rio2 and Tsr1 are also 
released and Rio1 enters the assembly pathway (Figure 1.9). However, the exact function of 
Rio1 is still unclear. Finally, data from the Tollervey lab has confirmed that the Rio1-associated 
particle in the late stages of maturation pathway contains Dim2 and Nob139, 45. 
 1.10 Rio2 as an ATP-Dependent rRNA Binding Protein 
 As mentioned earlier, the Rio2 is required for the release of hEnp1 and hLtv1 from pre-
40S ribosome in the cytoplasm46. Interestingly, the physical presence of Rio2 but not its kinase 
activity is necessary for the release of hEnp1 from cytoplasmic 40S precursor. In fact, Rio2 
kinase47 activity is not essential in ribosome assembly48. A Rio2 mutant in which the kinase 
activity is abolished can still support growth but only when overexpressed. We believe that the 




state even in the presence of competing phosphatase activity. Alternatively, Rio2 may simply be 
an ATP-dependent RNA-binding protein, perhaps modulated by its own autophosphorylation48. 
 Furthermore, incubation of Rio2 containing pre-40S particles with radiolabeled ATP in 
yeast resulted in no labeling of the pre-40S subunit, suggesting that there are no substrates for the 
Rio2 protein on the pre-40S particle49.  In eukaryotes, it is well established that the functional 
role of the Rio kinases, especially Rio1 and Rio2, is the maturation of the small subunit of the 
ribosome50. In Saccharomyces cerevisiae (budding yeast) both Rio kinases are essential and 
deletion of either one is lethal.  
 With the goal of elucidating the function of Rio kinases, for several years scientists have 
been looking for Rio kinase family substrates. Despite years of study in this area, the 
identification of protein substrates for these enzymes has been elusive50. However, all of the Rio 
kinases that have been purified and characterized have shown autophosphorylation activity.  
 A recent crystal structure of a eukaryotic Rio2 kinase from Chaetomium thermophilum 
revealed that ADP and a phosphoaspartate intermediate state was generated after incubation with 
ATP and magnesium ions48. This led to the observation of ATPase activity for this enzyme. The 
ATPase activity is measured to have turnover rate of 0.9 min-1 which is higher than that 
measured for autophosphorylation activity by 50-100 fold. These data, along with the 
observation that the Rio2 kinase likely binds the pre-40S particle with its active site inaccessible 
to protein substrate, led to the conclusion that Rio2 functions as an ATPase in the maturation 
steps of the pre-40S. 
 1.11 Objectives 
 The ultimate goal of chapters 5 and 6 is to understand the mechanism of the phosphoryl 




crystal structure of Ct-Rio2 in presence of sodium orthovanadate that mimics the transition state 
analog of phosphoryl transfer.  
 The ultimate goal is to regulate cell proliferation by possibly modulating the rate of 
ribosome biogenesis. Towards this ultimate goal, the focus of my research was to target the non-
ribosomal protein, Ct-Rio2 by asking the following questions: 
 What is the structure of Ct-Rio2 in presence of transition state analogs? 
 What is the function of catalytic loop in the active site of this protein? 
 What is the mechanism of the phosphoryl transfer from the ATP to the Asp residue? 
 Can Rio2 act as the evolutionary origins of the eukaryotic protein kinases? 
 How does the structure of Ct-Rio2 predict the interaction with the ribosomal particles? 
 How does Rio2 protein interact with ATP? 
 How does the Rio2 protein undergo conformational changes and perform catalysis? 
 To address these questions, I solved the crystal structure of Ct-Rio2 with the AMP and 
ADP bound in presence of sodium orthovanadate51. I will describe this complex in chapter 6. In 
chapter 7, I will focus on functional and mutational studies of Ct-Rio2 and describe whether the 









 Figure 1.1 Mycobacterium tuberculosis and skin test: TB is an infectious disease 
caused by Mycobacterium tuberculosis (Mtb). According to the skin test results one third of the 


















 Figure 1.2 Global tuberculosis report: In 2014, 8.7 million chronic cases of TB were 
reported, leading to1.4 million deaths. Geographically, the burden of TB is highest in Asia and 
Africa. India and China together account for 40% of the world’s TB and Africa has 24% of the 
























 Figure 1.3 TB pathophysiology: 1) Infection via inhalation of droplets; 2) Ingestion of 
organisms by macrophages; 3) Multiplication within macrophages; 4) Minimal inflammatory 
response; 5) Extension of organisms into the bloodstream; 6) Hypersensitivity reaction; 7) 










 Figure 1.4 The Mtb’s cell wall is consisted of several layers including phthiocerol 
dimycocerosate (DIM/DIP) layer, mycolic acids, arabinogalactan (AG), and peptidoglycan, 












         Figure 1.5 T7SS is encoded by ESX-1: ESX-1 is a specialized protein secretion system 
that is encoded by genes of region of difference 1 (RD1) and its extended regions. RD1 is 
comprised of nine genes (Rv3871 to Rv3879c), which are deleted from the primary cause of 
attenuation of the mycobacterium bovis bacille Calmette Guérin (BCG) vaccine strain. That is 


















 Figure 1.6 The representation of rRNA maturation: The 90S complex is cleaved on 
the 35S pre-rRNA at processing sites A0, A1 and A2, within the large 90S complex, to produce 
the pre-40S and the pre-60S particles.  The pre-40s particle is rapidly exported to the cytoplasm 
but the pre-60S particle remains in the nucleolus and undergoes a complex maturation pathway 











 Figure 1.7 Formation of ribosomal beak: In the cytoplasm, the major structural 
rearrangement that occurs on the pre-40S is the formation of the ribosomal “beak” structure that 
requires a cascade of phosphorylation and dephosphorylation events. Cryo-EM and biochemical 
studies have revealed that the formation of the beak is concomitant with the release of assembly 




























  Figure 1.8 Schematic representation of 40S subunit maturation in Saccharomyces 
cerevisiae: Pre-40S particles at different stages of assembly are purified using TAP to obtain the 
systematic information about cytoplasmic synthetic pathway of maturation. In the cytoplasm, the 


















 Figure 1.9 Schematic representations of ribosomal protein and rRNA binding sites: 
In the 40S structure model, the Rio2-binding site is located near the Rpss15. Leger-Silvestre et al 
have reported that the pre-40S ribosome that lacks Rps15 fail to bind Rio2 and be exported to 
cytoplasm. In bacteria, the Rps18 and Rps16 homologues (S13 and S9) are phosphorylated at 














Chapter 2: Purification and Crystallization of EspB 
 Protein crystallography dates back to 1934 when J.D. Benal and Dorothy Crowfoot 
obtained crystals and diffraction of hydrated pepsin crystals52. The first protein crystal structure 
was later solved for the sperm whale myoglobin in the late 1950s by Max Perutz and Sir John 
Cowdey Kendrew for which they both received the Nobel Prize in chemistry in 196253. Since 
then over 108,395 biological macromolecular structures have been solved and deposited to the 
protein data bank (PDB). Along with the increased number of solved protein structures, x-ray 
crystallography methods have also advanced with better detectors and improved software for 
structure determination.  
 However, one obstacle that crystallographers face is the phase problem that arises during 
data collection when the crystal diffracts x-ray beams that are recorded as reflections. These 
reflections are treated as complicated waves and the ultimate goal of a crystallographer is to 
obtain an electron density map that reveals the molecular shape of the protein. In order to obtain 
the electron density map the amplitudes, frequencies and phases have to be determined. Only two 
of these parameters are directly acquired during data collection, the amplitude and the 
frequencies. Unfortunately, the phases cannot be determined directly and methods for acquiring 
phases have been developed that include molecular replacement and single wavelength 
anomalous dispersion (SAD).  
 Molecular replacement uses phases from a previously solved crystal structure as initial 
phases for the new protein. For molecular replacement to be successful, the sequence identity 
between the new protein and the known protein, also known as the search model, has to be at 
least 30%. Unlike molecular replacement, SAD phasing relies on heavy atoms to obtain phases 




modified amino acids during expression. The most common heavy atom is selenium and it is 
incorporated into the protein during expression in media that has methionine replaced with 
selenomethionine (Se-Met). Once data is collected, the heavy atoms are located by Patterson 
maps and the initial phases are calculated and then improved by density modification.  
 The T7SS and the ESX-1 secretion pathway are not fully understood and obtaining the 
crystal structure of EspB could provide information regarding the T7SS and the transport 
mechanism of this protein16. We could not use molecular replacement for this protein because 
there was no known search model for EspB. Therefore, the common heavy atom, selenium, is 
incorporated into the protein during expression in media that has methionine replaced with 
selenomethionine (Se-Met). The crystal structure of EspB containing the selenium in the 
structure was obtained in our lab, previously. In this chapter, I will explain how both of the Full 
length EspB and the EspB292 were purified in the presence and absence of selenium for the 
crystallization and characterization studies that are described in chapters four.   
2.1 Expression of EspB292 
2.1.1 Expression of EspB in the Presence of Selenium 
 Two constructs of EspB from M. Marinum10, EspB residues 1-292 and EspB residues 1-
346 has been expressed, purified and crystallized by my colleague Irene Njeri.  For information 
on this project the reader is referred Irene’s dissertation. These constructs were designed based 
on a limited proteolysis results that identified EspB292 as a stable fragment. Both of these 
constructs have been prepared and expressed in 1L of seleno-methionine minimal media 
(Shanghai, Medilon Inc) with 34 μg/mL chloramphenicol and 100 μg/mL ampicillin, to generate 




OD600 of the culture has reached 1.2, 1 mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG) is 
added to the media for induction and expression is preceded at 18°C for 24 hours. The 
2.1.2 Expression of EspB in the Absence of Selenium 
In a similar procedure, I purified both EspB292 and Full-length EspB (FL-EspB) proteins 
in the absence of Se-Met. The constructs from M. Marinum were designed based on the limited 
proteolysis results and was further expressed, purified and crystallized. EspB plasmids with N-
terminal histidine tags were transformed to RosettaTM(DE3) pLysS E.coli cells (Novagen) and 
were expressed with 34 μg/mL chloramphenicol and 100 μg/mL ampicillin (Figure 2.1).  
2.2 Purification of EspB292 and FL-EspB 
 The media was prepared using 4L flasks that were previously washed with soap and 
distilled water. Each flask was then filled with 1 L distilled water and 20 g LB Broth media 
without selenium. These solutions were autoclaved for 1 hour and were used to grow bacterial 
cells in large scale. The overnight culture in the same way was prepared using 500 ml flask that 
was filled with 100 ml water and 2 g of LB Broth media. To the autoclaved media in the small 
flask, 100 μg/mL carbenicillin and 34 μg/mL chloramphenicol were added. The frozen bacterial 
cells were kept at -80ºC as the glycerol stocks. The cells from glycerol stock (in -80ºC freezer) 
were added to the small flask. This step was done very quickly so that the glycerol stock 
wouldn’t thaw. After adding the cells, the glycerol stock was stored back in -80ºC freezer and the 
flask was covered with aluminum foil and was grown in 37ºC shaker overnight. 
 The next day 100 μg/mL carbenicillin and 34 μg/mL chloramphenicol, that were freshly 
prepared, were added to the large 4 L flasks. The flasks were kept in 37ºC for 30 minutes. Then, 
10ml of overnight culture was added to each 4L flask using a clean disposable pipette and the 




three hours the flasks were taken to the 18ºC shaker to cool down and after 10 minutes 1 ml 
IPTG was added to each flask and the flasks were left at 18ºC to shake overnight. The IPTG was 
added to the media for induction and expression that proceeded at 18°C for 24 hours.  
The cells were centrifuged at 5,000 rpm and 4°C for 20 minutes using a Sorvall 
centrifuge (Dupont) with a SLC 4000 rotor. The bacterial pellets could be stored at -80ºC to be 
resuspended later. In my experiment, right after the centrifugation the bacterial cells were 
resuspended in lysis buffer containing 50 mM Tris pH 8.0, 200 mM NaCl, 0.05% β-
mercaptoethanol, 10% glycerol and one tablet of protease inhibitor. The resuspended bacterial 
cell pellet was subsequently, lyzed using 3 ml bugbuster followed by French press and the lysate 
was centrifuged at 4°C and 15,000 rpm for 50 minutes using a Beckman Coulter ultracentrifuge 
with a 45 Ti rotor.  
The supernatant was next filtered and loaded onto a pre-equilibrated 5 mL HisTrap HP 
column (GE healthcare) that was attached to a Fast Protein Liquid Chromatography (FPLC) 
system at the flowrate of 2.5 ml/min. The Histrap column was previously, washed and 
equilibrated with several rounds of buffer A and buffer B.  
Buffer A was prepared using 25mM Tris pH 8, 200mM NaCl and 0.05% BME and 10% 
glycerol. Buffer B was prepared using 250mM Imidazole, 25mM Tris pH 8 and 200mM NaCl, 
10% glycerol and 0.05% BME (Figure 2.2). 
After the lysate was loaded on the column, it was washed with 10 column volumes of 
lysis buffer (Buffer A) to remove any unbound protein. Subsequently, the bound protein was 
subjected to an imidazole gradient of 20 mM to 250 mM and EspB eluted between 100 mM and 
150 mM of imidazole. Partially purified fractions were pooled together and transferred to a 




cleave the histidine tag. EspB292 was dialyzed overnight at 4°C against 20 mM Tris pH 8.0, 50 
mM NaCl, 0.05% β-mercaptoethanol and 10% glycerol. After cleavage the protein was loaded 
onto a pre-equilibrated 5 mL HisTrap HP column (GE healthcare) and was washed with the same 
buffer that was used for dialysis. The cleaved protein was supposed to be collected in the flow 
through. The cleaved protein was then concentrated to 5ml and was further purified by size 
exclusion chromatography using a Superdex 200 column (GE healthcare) equilibrated in 10 mM 
HEPES, 50 mM NaCl and 0.05% β-mercaptoethanol at pH 7.5. All purification steps were 
monitored by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) for purity 
(Figure 2.3). 
2.3 Crystallization of EspB292 and FL-EspB 
Purified EspB292 was concentrated to 25mg/mL and was subjected to robotic sparse 
matrix screening using Phoenix Liquid Handing System (Art Robbins). The procedure is again 
followed from Irene’s dissertation and commercially available matrix screens, Index (Hampton), 
Cyros (Qiagen), PEGs suite (Qiagen), Wizard I, II and III (Emerald Biosystems) were used for 
initial crystal screening in 96 well plates with three different protein to well solution ratios (1:2, 
1:1, 2:1). Crystals that were observed during the initial screening were small and didn’t generate 
a good diffraction quality crystal. For Se-Met292, three different crystals were produced in our 
lab by Irene. The crystal with diamond-shaped in Wizard I and III suite grew in 1.2 M NaH2PO4, 
0.8 M K2HPO4, 0.1 M CAPS pH 10.5, 0.2 M Li2SO4 (Figure 2.4). Diffraction quality crystals 





Following the similar procedure, I tried the crystallization of EspB292 and FL-EspB in 
presence and absence of copper ions. Although several crystals were observed, none of them 
diffracted to a high quality and resolution. 
Many factors influence the likelihood of crystallization of a protein sample. Some of 
these factors include protein purity, pH, concentration, temperature, precipitants and additives. 
The more homogeneous the protein solution is, the more likely that it will crystallize. Typically, 
protein samples above 97% purity are considered suitable for crystallization, although high 
purity is neither necessary nor sufficient for crystallization. Solution pH can be very important 
and in extreme cases can result in different packing orientations. Buffers, such as Tris-HCl, are 
often necessary for the maintenance of a particular pH, Precipitants, such as ammonium 
sulfate or polyethylene glycol, are usually used to promote the formation of protein crystals. In 
the case of EspB protein one reason for the low quality of crystals is the degradation of this 
protein over time. During the incubation of the crystals at 20ºC the solution of EspB could get 
less homogeneous because of the probable cleavages at different sites. This was more observed 
for the full length EspB. Therefore, only selenium methionine crystals were good enough for 
diffraction.   
2.4 Data Collection and Structure Determination 
Data that has been collected at 100K at the NE-CAT beamline at the Advanced Photon 
Source (APS), Argonne, IL, USA were indexed, integrated and scaled. The diamond-shaped 
crystals of EspB292 grown with the selenium diffracted to 2.5 Å. The crystals belong to P21 
space group and the unit cell dimensions are a= 173.448 Å, b= 81.703 Å, c= 267.467 Å and 





2.5 Overview of the Structure of EspB 
 Based on the crystal structure the cleaved EspB292 has 16 monomers in the asymmetric 
unit (molecules A-P) that are arranged into a set of four homotetramers (Figure 2.5). Two sets of 
these tetramers (tetramers 1 and 3; tetramers 2 and 4) are arranged parallel to each other. Contact 
is observed between the C-terminal loop of one tetramer and the C-lobe helices of the adjacent 
tetramer. Every homo-tetramer has two monomers (monomers A and B and monomers C and D) 
that are arranged anti-parallel to each other creating an interacting interface and a central helix 
bundle (Figure 2.6-2.7). Contact is also observed between the C-lobe helices of two monomers 
within the tetramer. For instance monomer A interacts with monomer D and monomer B 
interacts with C via the C-lobe helices (Figure 2.8). The monomers have regions on the N- and 
C-terminus that lack electron density due to disorder and flexibility on these ends.  
 EspB292 is composed of long, antiparallel coiled-coil helices. EspB292 can form hetero 
dimer with Rv3879c and be translocated through the inner membrane. Based on the crystal 
structure we can also observe that EspB can adopt a homodimer fold.   
 2.6 EspB can Adopt a Homodimer Fold 
 The helix-turn-helix domains of CFP10 and the N-terminal domain of EspB292 residues 
1–92 are roughly superimposable, each with a characteristic YxxxD motif at the turn. EspB292, 
residues 135–226, and ESAT-6, residues 2–104, are also roughly superimposable, each with a 
WxG motif at the turn of the second helix-turn-helix subdomain (Figure 2.9). In EspB292, these 
two subdomains form an extensive interface of non-covalent interactions, and the linker 
connecting them adopts an extended conformation that anchors loosely to the helical bundle 




 EspB292 possess features that are not found in ESAT-6 and CFP10. Notably, helix 3, 
helix 6, and helix 7 of EspB292 create a ‘‘helical tip’’ that is rich in solvent-exposed 
hydrophobic/aromatic/acidic residues (Figure 2.10). The tip ends in an extended polyproline 
stretch (residues 270–288) that sandwiches between the subdomains through hydrophobic 
interactions provided by prolines and aliphatic side chains.  
 2.7 EspB can Target the EccCb1 ATPase 
 EspB has a bipartite signal sequence that targets the EccCb1 ATPase. The EspB292 
crystal structure reveals the unique relative disposition of multiple characteristic ESX sequence 
motifs, including a structured view of the helical export arm. In this work, we define the export 
arm as EspB292 residues 78–93, corresponding to the appendage that is dynamic in the structure 
and lacking electron density. The prevalent view is that residues from the export arm align on the 
same helical face upon binding the EccCb1 ATPase, targeting ESX secreted substrates for 
secretion  
 2.8 Secretion of EspB/Rv3879c Follows Pairwise Dependency  
The three dimensional structure of a protein provides insights into its probable function. 
Therefore, proteins with similar functions often tend to adopt similar folds even when they have 
very low sequence similarity. The results obtained from the x-ray crystallography indicate novel 
functional roles for the secreted proteins Rv3881c (EspB). The 3D fold structure of EspB292 
shows a helix-turn-helix fold at the N-terminal of the protein and the C terminal end of EspB292 
has a WEG tripeptide motif at the position 176–178 that is similar to the WXG motif observed 
for the ESAT-6 like family of proteins. Based on previous results, the N-terminal region of 
Rv3879c displays helical regions followed by coiled-coil regions, similar to fibrinogen fold. 




helix-bundle similar to CFP-10/ESAT-6 pair. Interestingly, the 3D fold analysis of EspC protein 
also adopts a similar fold to that of ESAT-6 and EspB and the N-terminal region of EspA 
exhibited WXG motif. With regards to the secretory proteins of the ESX-1 secretion pathway, 
the current analysis indicates that the secretory protein pairs have a preference to adopt a four-
helix-bundle structure. While the CFP-10/ESAT-6 and EspA/EspC pairs were previously 
reported to have such a structure, the present analysis suggests that the other secretory protein 
pairs EspB/Rv3879c may also adopt similar structures. 
2.9 Inner Membrane Translocation of EspB/Rv3879c Pair 
Previous studies have provided experimental evidences that Rv3868 interacts with CFP-
10/ESAT-6 and EspA/EspC pairs and helps in their multimerization. This multimeric protein 
assembly as well as EspB/Rv3879c is recognized by Rv3870 that is a member of Ftsk/SpoIIIE 
family of DNA translocase proteins. Rv3870 contains two transmembrane helices and a single 
FtsK ATPase domain and is known to interact with another cytoplasmic FtsK/SpoIIIE family 
protein Rv3871 that contains two FtsK ATPase domains. The α and β units of the FtsK domain 
containing proteins are known to multimerize to produce a hexameric ring with an inner diameter 
of 30Å. During cell division, this hexameric multimer acts as a DNA pump which translocates 
double stranded DNA with diameter of 20 Å. The α and β units domains of Rv3870/Rv3871 
pairs also forms a hexameric ring, similar to that formed by a hexamer of FtsK proteins. 
Structural analysis of CFP-10/ESAT-6 four-helix-bundle diameter has previously shown to be 
approximately 20–23 Å. Our findings suggest that each EspB292 monomer is similarly alpha 
helical and is roughly shaped like a cylinder with 103.6 Å length and a diameter of 16.1 Å that 
would perfectly fit and translocate through the hexameric ring of Rv3870/Rv3871 pairs. This 




four-helix substrates similar to that used by FtsK family proteins for the translocation of double 
stranded DNA. Therefore, the Rv3870/Rv3871 hexameric ring of T7SS may be a good example 
of machinery that has evolved from a specialized double stranded DNA translocator to a protein 
transporter.  
 The consecutive step after recognition of the secretory proteins by Rv3870/Rv3871 ring 
is translocation of these proteins through the inner membrane pore of Rv3877. The diameter of 
the inner pore considering a compact arrangement of the helices is determined to be 
approximately 26 Å or larger upon incorporating the side-chain lengths and interactions. Thus, 
this data also suggests that the substrate pairs (four-helix-bundles) of the ESX-1 secretion 
pathway would be able to fit into and be translocated along the inner pore of Rv3877. 
2.10 Secretion Regulation of CFP-10/ESAT-6  
Once EspB pairs up with Rv3879c, it co-secretes with CFP-10/ESAT-6 and EspA/EspC 
through Rv3877 inner pore to the periplasm-like space. These multimers thereby, reach MycP1 
protease which is anchored to the Rv3877 by a C-terminal transmembrane helix, and is located in 
the periplasm-like space. 
Therein, MycP1 plays a dual role in regulating the secretion activity of ESX-1. MycP1 
interacts with Rv3877 and opens the pore to enable protein secretion. Thus, the knock-out of 
MycP1 has shown to completely abolish secretion. Nonetheless, its protease activity negatively 
regulates secretion via EspB. The presence of a mutant MycP1 without any protease activity has 
shown to increase the secretion of CFP-10/ESAT-6 and accumulation of EspB in the periplasm-
like space. These findings suggest a probable regulatory role of EspB cleavage by this serine 
protease (MycP1) in the periplasm-like space since the cleavage of EspB by MycP1 leads to 





 The crystal structure of EspB292 has 16 monomers in the asymmetric unit which is 
composed of long, antiparallel coiled-coil helices. Based on the structure EspB292 can interact 
with other proteins and form heterodimers and interact with itself and form homodimer. To form 
heterodimers the helix-turn-helix domains of the N-terminal domain of EspB292 residues 1–92 
are used. EspB292, residues 135–226, and ESAT-6, residues 2–104, are also roughly 
superimposable, each with a WxG motif at the turn of the second helix-turn-helix subdomain. 
The WxG motif is required for the formation of the dimers. It’s been shown in TB that at least 
one of the monomers in a dimer should have the WxG sequence.  
 EspB292 possess features that are not found in ESAT-6 and CFP10. Notably, helix 3, 
helix 6, and helix 7 of EspB292 create a ‘‘helical tip’’ that is rich in solvent-exposed 
hydrophobic/aromatic/acidic residues. The tip ends in an extended polyproline stretch (residues 
270–288) that sandwiches between the subdomains through hydrophobic interactions provided 
by prolines and aliphatic side chains.  
 The crystal structural information also reveals that EspB has a bipartite signal sequence 
and structure that targets the EccCb1 ATPase. The EspB292 crystal structure reveals the unique 
relative disposition of multiple characteristic ESX sequence motifs, including a structured view 
of the helical export arm. In this work, we define the export arm as EspB292 residues 78–93, 
corresponding to the appendage that is dynamic in the structure and lacking electron density.  
Previous studies have provided experimental evidences that Rv3868 interacts with CFP-
10/ESAT-6 and EspA/EspC pairs and helps in their multimerization54. This multimeric protein 
assembly as well as EspB/Rv3879c is recognized by Rv3870 that is a member of Ftsk/SpoIIIE 




diameter of 30Å. Structural analysis of CFP-10/ESAT-6 four-helix-bundle diameter has 
previously shown to be approximately 20–23 Å. Our findings suggest that each EspB292 
monomer is similarly alpha helical and is roughly shaped like a cylinder with 103.6 Å length and 
a diameter of 16.1 Å that would perfectly fit and translocate through the hexameric ring of 
Rv3870/Rv3871 pairs.  
Once EspB pairs up with Rv3879c, it co-secretes with CFP-10/ESAT-6 and EspA/EspC 
through Rv3877 inner pore to the periplasm-like space. These multimers thereby, reach MycP1 
protease which is anchored to the Rv3877 by a C-terminal transmembrane helix, and is located in 


















EspB292 construct:  
N´---6x His Tag--- TEV Site--- EspB292---C´ 
 Full Length EspB: 
 N´---6x His Tag--- TEV Site--- FL-EspB---C´ 
           Figure 2.1 Schematic representation of EspB constructs: EspB constructs are designed 



























 Figure 2.2 Preparative gels of EspB292 after first His-trap column (A) and size 
exclusion chromatography (B): Lane M is the protein ladder. Gel of EspB292 displays pure 






























 Figure 2.3 Preparative gels of FL-EspB after size exclusion chromatography: Lane 




























































             Figure 2.5 Overall structure of EspB292: EspB292 has 16 monomers in the 
















 Figure 2.6 Structure of EspB has four homotetramers: Two sets of these tetramers 
















           Figure 2.7 Structure of EspB has four homotetramers: Contact is observed between 

























           Figure 2.8 Overall monomeric structure of EspB: The monomer is mostly helical and 
























         Figure 2.9 Interface between monomers A and D: Black dashed lines are hydrogen 







           Figure 2.10 Interface between monomers A and B: Black dashed lines are hydrogen 














Chapter 3: Oligomeric State Characterizations of EspB 
 3.1 Type VII Secretion System   
 As discussed earlier in chapter one, Mtb is capable of manipulating its environment by 
delivering virulence factors during infection55. The secretion of variety of virulence factors such 
as ESAT-6 and CFP10 proteins evade, modulate and control host immune responses and creates 
a favorable environment for the intracellular survival and replication of Mtb56. To penetrate 
through the highly protective, and hydrophobic waxy coating of mycolic acids these virulence 
factors are exported by a specialized secretion pathway that is called Type VII secretion system 
(T7SS). 
  Based on the T7SS, we know that the virulence of Mtb is initialized by phagosomal 
signals that trigger the transcription and secretion of two pairs EspA/EspC and CFP-10/ESAT-6. 
Once expressed, Rv3868 assembles these pairs into multimers that are subsequently recognized 
by Rv3871 and Rv3870. This translocase pore facilitates the ATP-dependent translocation of the 
substrates through the inner membrane pore protein (Rv3877)57. Thereafter, the interaction of the 
N-terminal gate-like domain of Rv3877 with MycP1, a serine protease, opens the pore enabling 
translocation of the substrate assembly from cytoplasm to the periplasm-like space17, 19, 20, 22, 58, 59. 
Ultimately, the substrate assembly crosses the mycomembrane through a channel formed by 
Rv3869, Rv3882c and the four proteins of MCE cluster 1 (Mce1B, Mce1C, Mce1F and Rv0177) 
(Figure 3.1).  
 3.2 Role of EspB in Type VII Secretion System 
 In this proposed model we don’t know the much about EspB protein and its transport 
mechanism. EspB, as well as ESAT-6 and CFP-10, is a very important virulence factor. EspB in 




protein are as attenuated for virulence as those lacking the entire secretion apparatus17, 20, 21, 55, 57, 
59, 60. Knocking out EspB in the related pathogen Mtb abrogates red blood cell hemolysis, 
eliminates macrophage cytotoxicity, inhibits intracellular growth and phagosome maturation and 
completely attenuates virulence.  
3.3 EspB292 Oligomization in Literature 
Based on previous findings, EspB cleavage regulates the controlled secretion of CFP-
10/ESAT-6 and EspA/EspC multimers. Our crystallographic studies, furthermore, suggested that 
upon cleavage EspB aggregates to a set of four homotetramers. Therefore, the controlled 
secretion of four-helix-bundles might be as a result of the EspB aggregation. It has been shown 
by Strynadka et al that in light scattering and negative stain electron microscopy (EM), EspB 
from Mtb has a propensity to oligomerize, revealing the potential for EspB to serve as structural 
subunits in the construction of cell wall-associated architectures of mycobacteria as its widely 
hypothesized. To clarify the components that affect oligomerization of the EspB292, we set up 
experiments that would mimic the phagosomal environment to find out how the protein self–
assembly occurs in biologically relevant conditions. 
 While our structural studies of the N-terminal domain of EspB292 provide insight into 
the molecular basis of ATPase-mediated export, subsequent analysis of our full length Mtb EspB 
revealed that EspB has the capability of forming higher order oligomeric states. Immediate clues 
of EspB oligomerization arose during purification, with protein eluting on a gel filtration column 
at multiple retention times, suggesting that this protein can self-associate in a concentration-
dependent manner.  
 To more accurately determine the subunit stoichiometry of the higher molecular species, 




(SEC-MALS) analysis. The SEC-MALS experiment detected a monodisperse peak of molecular 
weight 52 kDa (corresponding to mass of a single full length EspB as well. They also confirmed 
the oligomerization of EspB by analytical ultracentrifugation sedimentation velocity experiments 
that identified a low molecular weight 2.1S species (44 ±5 kDa) and a high molecular weight 
species with a sedimentation coefficient of 10.5S (317 ± 41 kDa). To characterize the structural 
properties of the full length EspB oligomer, they subjected the peak fractions to gel filtration run 
to negative stain EM analysis. The data shows ring-shaped structures that were evenly distributed 
across the grid.  
3.4 Results and Discussion 
3.4.1 EspB292 Oligomization  
Many proteins function through protein complex assemblies therefore, studying protein-
protein interactions in biologically relevant conditions, can often be a crucial step in 
understanding the fundamentals of many biological processes. Based on the crystal structure of 
EspB292 protein, in the non-covalent protein complex assemblies, the individual protein 
members reside in close proximity of each other. The close proximity of the lysine residues was 
utilized to identify a proper cross-linker (BS3) with respective spacer arm length (of 11.4Å) that 
could covalently link two interacting proteins. Hence, the chemical cross-linking experiment was 
performed to first link the proteins covalently, followed by well-established protocols such as 
SDS-PAGE for identification of the protein assemblies.  
3.4.2 BS3 Cross-Linking Protocol 
Immediately before use, a 50mM solution of BS3 (Bis-Sulfosuccinimidyl-suberate 61) 
was prepared by dissolving 10 mg BS3 in 350 µL of 25 mM Sodium Phosphate, pH 7.4 buffer62. 




added to the protein sample so that the final cross-linker concentration was between 0.5 to 5 mM. 
The sample was allowed to react at room temperature for 2 hours on ice. The unreacted BS3 was 
quenched with 60 mM Tris buffer and was allowed to react for 15 minutes at room temperature. 
Proteins of interest were then identified using SDS denaturing gel63.  
3.4.3 EspB Oligomerization at High Concentrations 
Based on our chemical cross-linking experimental observations and mass spectrometric 
studies, EspB292 proteins form complex assemblies only at high concentrations (>100 µM) 
(Figure 3.2-3.4). Therefore, the cleaved EspB protein that is secreted into the extracellular 
milieu is capable of forming higher order oligomeric states and therefore, forming large protein 
assemblies when it accumulates in the small periplasmic space. Since the truncation of C-
terminus of EspB is necessary to regulate the secretion of virulence factors, the protein-protein 
tetramer network is probably competing with four-helix-bundles for translocation (through the 
mycomembrane) using the same machinery. 
3.4.4 EspB292 Assembly Formation in Presence of Heavy Metal Ion  
Macrophages employ evolutionarily conserved mechanisms such as microbial ingestion, 
followed by maturation of the phagocytic vacuole (phagosome) to kill bacteria. During 
maturation process, macrophages utilize different mechanism to kill microbes, including 
phagosomal acidification and, the selective manipulation of various ions in the phagosomal 
lumen.  
Phagosomal acidification is mainly established by the action of the vacuolar H+-ATPase 
(v-ATPase) and the complementary roles played by other transporters and channels to 
counterbalance the ionic gradient of H+ across the membrane (Figure 3.5). For example the 




counterion transport that maintains vacuolar acidification. A counterflux of cations, such as the 
efflux of K+, may also assist vacuolar acidification64. The immature mycobacterial phagosome in 
resting cells is considered to be mildly acidic (pH 6.5) but upon activation by the adaptive 
immune system, the pH is further decreased. Several lipids and proteins interfere with the 
phagosome maturation and resist the acidification65. To test whether EspB accumulation in 
periplasmic space would contribute to or be affected by the acidification machinery of the 
phagosomal milieu, the EspB aggregation was studied in different pHs ranging from 5 to 9. Our 
study reveals that pH variations don’t affect the oligomeric state of EspB56, 66. 
 Alternatively, the selective manipulation of various heavy metal ions in the phagocytic 
vacuole can lead to destroying the bacteria. Hereby, we will discuss the role of essential 
phagosomal nutrients and trace elements on the oligomeric state of the EspB292 protein.  
 Both the salts and ions can play a dominant role on the proton and electron gradients’ 
maintenance that accompany phagosome acidification.  For instance, several recent studies have 
indicated that within the first hour of phagocytosis of M. tuberculosis a decrease in vacuolar 
concentration of Ca2+ and K+ can be observed which perhaps assists vacuolar acidification 13. 
Within the next 24 hours the concentrations of these ions increase along with phagosomal 
concentration of sulphur and chlorine. Additionally, salts, metals and trace elements can impact 
the antimicrobial mechanisms and the biology of the pathogens. For example the movement of 
ions modifies cell activation and impacts the antimicrobial mechanism by inflammatory 






 3.5 Iron and TB 
 One of the metals that significantly affect the host–pathogen interactions of pathogenic 
intracellular microbes, such as Mycobacteria, Salmonella, and Legionella, is iron5, 67. 
Accumulation of the iron/manganese transporter at the phagosomal membrane leads to depletion 
of these metals at the phagosomal lumen within the first hours of infection. Iron depletion, 
thereby, arrests microbial intracellular development and constrains the microbial growth. In 
mycobacterium tuberculosis’ phagosomal lumen, iron plays a biphasic behavior 68. Its content 
first decreases up to four-fold within the first hours of infection, and increases from 5 to 25 folds 
during the following 24 hour68-71. Since high level of iron promotes the growth and infection of 
the mycobacterium tuberculosis, the iron chelation therapy has been recently studied to reduce 
the replication of Mtb and restore the host defense mechanism (Figure 3.6).  
 3.6 Zinc and Copper and TB 
  Other heavy metals that accumulate in large amounts inside the mycobacterial vacuole 
within the first 24 hours are Zn2+ and Cu2+. Although several recent studies have revealed the 
role of phagosomal ions such as iron, zinc69, 70, 72 and, copper69, 73 and other chemicals in the 
control of pathogens, the information on the evolved mechanisms by which intracellular 
pathogens circumvent or exploit these conditions of host cell is limited. For instance, we know 
that to resist metal intoxication, microbes commonly up-regulate expression of efflux pumps of 
the P-type ATPase, but the role of these elements in phagosome biology remains elusive. One of 
the several questions that remain to be answered is: why Mtb deficient in expression of these 
transporters exhibits impaired intracellular survival? In other words, how does the content of any 




 3.7 EspB Oligomerization in Presence of Iron and Copper 
 One key step to answer this question is to set up experiments that would mimic the 
phagosomal environment and study how the virulence factors are affected at each condition. To 
determine the effect of metal ions concentration on the EspB292 oligomerization, we compared 
the aggregation level of protein in various amounts of different metals. EspB exists mainly in its 
monomeric form in presence of many ions including Na+, K+, Cl-, Ca2+, Mg2+, Po43-, So42- and 
Zn2+. However, our findings further suggest that the aggregation of EspB292 can be significantly 
influenced by the content of the iron, and copper ions in the environment (Figure 3.7-3.10). 
Since the aggregation of EspB292 can alter the controlled secretion of essential virulence factors 
such as CFP-10 and ESAT-6, the maintenance or increase of the heavy metal concentration can 
ensure Mtb’s survival or promotion. 
 3.8 Summary  
Our findings suggest that the aggregation of EspB292 to tetramers neither depends on the 
pH of the periplasmic space nor is affected by ionic concentrations of Na+, K+, Cl-, Ca2+, Mg2+, 
Po43-, So42- and Zn2+. Nevertheless high level of heavy metal content of phagosomal environment 
within 24 hours of the infection can highly influence the aggregation of the EspB to higher order 
oligomeric complexes. Additionally, chemical cross-linking, and mass spectrometry studies 
confirm the formation of protein complex assemblies at high concentrations. Our analysis 
suggests functional roles for EspB provides insight into the pair-wise dependency of the 
EspB/Rv3879c secretion and its transmembrane translocation. 
 This study investigated the crystal structure and potential functions of the early secretory 




asymmetric unit that is arranged into a set of four homo-tetramers and therefore it forms high 
order tetrameric aggregations upon cleavage at the periplasmic space of the mycobacterium by 
mycP1. Since the cleavage of EspB is essential for the regulation of virulence factor’s secretion, 
we studied the phagosomal environmental conditions to investigate the elements that would 
impact the oligomerization of EspB.  
 Our findings suggest that the aggregation of EspB292 to tetramers depends on the 
protein’s concentration. Therefore, upon EspB translocation to the small periplasmic milieu it 
would stay as a monomer. Upon accumulation to a high enough concentration the truncation of 
C-terminus can induce the protein-protein tetramer network formation which may further alter 
outcome of M. tuberculosis macrophage infection.  
 With regards to the secretory proteins of the ESX-1 secretion pathway, the crystal 
structure of EspB also indicates that the secretory protein pairs have a preference to adopt a four-
helix-bundle structure. While the CFP-10/ESAT-6 and EspA/EspC pair was previously reported 
to have such a structure, the present study and previous in silico analysis by mande et al. 
suggests that the other secretory protein pairs (EspB/Rv3879c) also adopt similar structures.  
 We also observed that rather than C-terminus truncation of EspB by MycP1 protease, 
other conditions such as high heavy metal environment can also trigger the proteins aggregation 
and affect the outcome of the host-pathogen interactions to promote the disease. In recent years 
several studies have revealed the role of phagosomal ions such as iron, manganese, zinc and, 
copper and other chemicals in the control of pathogens. Unfortunately, the information on the 
evolved mechanisms by which intracellular pathogens circumvent or exploit these conditions of 
host cell is limited. Such mechanistic information can provide useful insights to develop better 




microbes commonly up-regulate expression of efflux pumps of the P-type ATPase, but the role 
of these elements in phagosome biology remains elusive.  
 One other crucial aspects of the ESX-1 secretion mechanism pertain to the translocation 
of secretory proteins through the mycomembrane. In spite of considerable experimental efforts to 
understand the ESX-1 secretion system, the components involved in protein translocation 
through the mycomembrane is currently not known. In conclusion, a better knowledge of how 
ancient mechanisms involved evolved to perform host defense and microbial virulence functions 
















           Figure 3.1 Proposed model of T7SS that is encoded by ESX-1: The phagosomal 
signals initialize the transcription and secretion of two pairs EspA/EspC and CFP-10/ESAT-6. 
Once expressed, Rv3868 assembles these pairs into multimers that are subsequently recognized 
by Rv3871 and Rv3870. These two FtsK family proteins form a translocase pore that the 
multimeric protein assembly is likely to pass through. Thereafter, the interaction of the N-
terminal gate-like domain of Rv3877 with MycP1, a serine protease, opens the pore, thus 
enabling translocation of the substrate assembly from cytoplasm to the periplasm-like space. 
Ultimately, the substrate assembly crosses the mycomembrane through a channel formed by 






         Figure 3.2 EspB292 SDS gel in presence of cross-linker: BS3 with respective spacer 
arm length of 11.4Å was used as the cross-linking agent that could covalently link two 
interacting proteins. Lanes 3 to 13 display the formation of protein assemblies as we decreased 
the crosslinker concentration (from 1.92 mM to 53µM). To all lanes except lane 1 BME was 













        Figure 3.3 EspB292 SDS gel in presence of cross-linker: Lanes 1 to 9 displays the 
formation of protein assemblies as we increased the protein concentration (1µM-100µM). To all 
lanes except lane 10 BME was added as the reducing agent. Lanes 10 and 11 are showing the 
pure protein without the crosslinker. Numbers between panels indicate sizes in kilodaltons. The 























        Figure 3.4 Mass spectrometry of EspB292 proteins: The MS displays the formation of 















        Figure 3.5 Phagosomal acidification: The acidification of phagosome is established by 
the action of the vacuolar H+-ATPase (v-ATPase) and the complementary roles played by other 
transporters and channels to counterbalance the ionic gradient of H+ across the membrane. For 
example the influx of anions such as Cl− via either the CFTR or the ClC family channels is the 













         Figure 3.6 Iron, zinc, and copper concentration: Early phagosome contains high 
concentration of Fe3+ which decreases within the next 24 hours after phagocytosis. The decrease 
in iron III ion concentration happens along with the increase in the concentrations of Cu2+, and 
Zn2+ ions as well as Sulphur and chlorine. Additionally, salts, metals and trace elements can 










         Figure 3.7 EspB292 assembles to higher order aggregation complexes upon increasing 
the concentration of copper from 1mM to 120mM: The native gel of 20µM EspB at all lanes 
















 Figure 3.8 Denaturing gel of 20µM EspB and 2.5mM BS3 cross-linker at all lanes in 

















         Figure 3.9 EspB292 assembles to higher order aggregation complexes upon increasing 
the concentration of iron (III) from 10µM to 10mM: The native gel of 20µM EspB at all lanes 

















 Figure 3.10 Denaturing gel of 20µM EspB and 2.5mM BS3 cross-linker at all lanes 














Chapter 4: Purification and Crystallization of Ct-Rio2  
 The purification of Rio2 family of proteins in eukaryotes has been tried by my colleague 
Vatsala Sagar for Rio2p and hRio2 and the efforts to obtain the structure of a eukaryotic Rio2 
failed75. In the case of Rio2p the crystals were small, and in the case of hRio2 poor solubility 
prevented crystal screening76.  
  4.1 Expression of the Ct-Rio Protein 
 Ever since the identification of Rio proteins in yeast, several Rio proteins have been 
expressed and purified in Escherichia coli, and their enzymatic properties and structural features 
were characterized. For instance, A. fulgidus Rio1 was expressed in E. coli as a fusion protein 
containing the N-terminal His tag followed by a tobacco etch virus (TEV) protease cleavage site.  
The tag was subsequently removed during protein purification and the enzyme is shown to be 
capable of autophosphorylation on Ser-108. A. fulgidus Rio2 with its native N terminus was also 
expressed and purified77, and it was also shown to be active in an autophosphorylation assay, 
although at a level much lower than that of Rio1. The site of autophosphorylation was 
determined to be Ser-12878.  
 In this chapter, I discuss the purification and crystallization of Rio2 from a thermophilic 
fungus, Chaetomium thermophilum (Ct-Rio2). The construct shown in Figure 4.1, was obtained 
from the laboratory of Dr. Ed Hurt in the Biochemistry Center, Heidelberg University, Germany.  
There were issues in the purification and crystallization of Ct-Rio2: it co-purified with a close 
molecular weight degradation product; it nonspecifically bound to RNA in the lysate; and 
crystals of Ct-Rio2 were small and did not diffract well. These problems were corrected by 




molecular weight contaminant, using a QTM column to separate RNA from ctRio2, and seeding 
with microcrystals to produce larger, better diffracting crystals (for more information the reader 
is referred to my colleague Vatsala Sagar’s dissertation). 
 4.2 Purification of Rio2 from Chaetomium Thermophilum  
 Following the optimized procedure outlined below Ct-Rio2 was designed and was further 
expressed, purified and crystallized. The p7-Ct-Rio2 vector (from the Hurt lab), transformed into 
E. coli RosettaTM(DE3) pLysS (Novagen), and was used to inoculate 100 mL culture which was 
expressed with 34 μg/mL chloramphenicol and 100 μg/mL ampicillin. The cells were grown at 
37°C while shaking at 250 rpm. The overnight culture was diluted 1/100 into four 4 L baffle 
flasks containing 1 L of LB with ampicillin and chloramphenicol. The four flasks were then 
incubated at 37°C with shaking at 250 rpm. Once the OD600 reached 0.6-0.8, 1 mM of Isopropyl 
β-D-1-thiogalactopyranoside (IPTG) was added to the media for induction and expression 
proceeded at 18°C overnight. The cells were centrifuged at 5,000 rpm and 4°C for 20 minutes 
using a Sorvall centrifuge (Dupont) with a SLC 4000 rotor. The bacterial pellet was stored at -
80°C.  
 The cells were centrifuged at 5,000 rpm for thirty minutes. The pellet was about 4-5 
grams per liter of cell culture. The cell pellets were frozen at -80°C. The frozen pellet was 
resuspended in 10 mL of Buffer A (200 mM NaCl , 10% glycerol, 50 mM Tris, pH 8.0, 2.5 mM 
MgCl2, 0.05% BME) per gram of cell pellet. 5 mg of DNAse, one Complete, EDTA free, 
protease inhibitor cocktail tablet (Roche), 2 mg of RNase A, 1ml of 10X BugbusterTM and 0.5 
mg of lysozyme/mL per liter of cell pellet were added to the solution. The cells were stirred at 




to pellet the cell debris. The supernatant containing the soluble protein was filtered through a 0.2 
micron filter.  
 The supernatant was passed over a GE Healthcare 5 mL His TrapTM column that was pre-
equilibrated with Buffer A. Only one His TrapTM column was used in order to overload the 
column with the supernatant. Overloading the column eluted the Ct-Rio2 at 30 mM imidazole 
and in pure and concentrated fractions. Overloading the column with protein allows the 
elimination of protein contaminants including the degradation product. Since Ct-Rio2 has higher 
affinity for the nickel column and binding sites on the nickel column are limited, Ct-Rio2 will 
compete with degradation products for binding to the column. The result is that the major protein 
contaminants will not bind to the column. Buffer B (200 mM NaCl, 10% glycerol, 50 mM Tris, 
pH 8.0, 2.5 mM MgCl2, 0.5 M imidazole, 0.05% BME) was used to elute the protein. 6% Buffer 
B was used to elute CtRio2 from the column. The column was washed with 20% Buffer B and 
then 100% Buffer B (Figure 4.2).  
 The concentrated and pure fractions were pooled together for TEV cleavage. Ct-Rio2 was 
concentrated to 10 mg/mL on a millipore centrifugal filter unit at 4°C. 10 mg of TEV protease 
was added to the Ct-Rio2, which was then dialyzed overnight in Buffer A at 4°C. In order to 
cleave the His tag from the N-terminus for each 1 mg/ml of concentration of Ct-Rio2, 1 mg/ml of 
TEV protease was necessary. With these concentrations most of Ct-Rio2 was found to be 
cleaved and eluted in the flow-through. 
 The next day, the His TrapTM column was equilibrated with Buffer A. Ct-Rio2 was 
passed over the column and the flow-through was collected and assumed to be cleaved protein. 





4.3 Ct-Rio2 Binds to RNA Nonspecifically  
 The Ct-Rio2 protein tends to binds to RNA and this binding makes purification steps a 
little difficult. There are two solutions for purifying the protein and get rid of RNA contaminants 
48. One is to add 2 mg of RNase A to the lysate in the lysis buffer and second is to pass the 
protein over an anion exchange QTM after the second His trap column during the last step of 
purification of Ct-Rio2. In the chromatogram of the elution of the protein from the QTM column 
two peaks appear, one for ctRio2 at a lower concentration of 300 mM salt, and one for RNA at a 
higher concentration of 500 mM salt. The second peak is RNA because it has a high affinity for 
the QTM column. Its A260/A280 absorbance ratio is over 2 and it shows no protein bands on the 
gel.  
The QTM column is an important step for purification. If RNA continues to remain bound 
to ctRio2, it would prevent Ct-Rio2 from forming crystals. The RNA is bound nonspecifically 
and consists of a variety of different RNAs. Any heterogeneity in the protein sample precludes 
the protein from crystallization. The pure protein was concentrated to 10mg/ml and was kept in -
80ºC.  
The cleaved protein was further purified by size exclusion chromatography one day 
before setting up the crystal screening trays using a Superdex 200 column (GE healthcare). The 
column was equilibrated in 50 mM Tris pH 8, 200 mM NaCl and 0.05% β-mercaptoethanol 
(Figure 4.3). All purification steps were monitored by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS PAGE) for purity. 
 4.4 Crystallization of Ct-Rio2 in Presence of ADP  
 Purified Ct-Rio2 was concentrated to 10 mg/mL and was subjected to robotic sparse 




matrix screens were used including Qiagen’s PEG Suite, Hampton’s Index Screen, Emerald 
Biosystems Wizard I, II, and III Screens, Hampton Research’s Natrix Screen and Qiagen’s Cryos 
Suite. Initial crystal screening was performed in 96 well plates with three different proteins to 
well solution ratios (1:2, 1:1, 2:1). The protein was co-crystallized with ADP/BeF2 and 
ADP/Na2VO3. The structure was expected to mimic the transition state of the phosphoryl transfer 
from ATP to Asp257 in Rio2’s active site and the subsequent hydrolysis of the aspartyl 
phosphate that could power late cytoplasmic 40S subunit biogenesis.  
 4.5 Crystallization of Ct-Rio2 in Presence of ADP/BeCl2/KF 
 Ct-Rio2 was crystallized in the presence of ADP, MgCl2, BeCl2 and KF. After setting up 
the initial crystal screenings the crystals started to show up in two weeks. Several crystals were 
obtained for each of the complexes. We obtained the diffraction data sets for Ct-Rio2/ADP/BeF2 
at 4 conditions with resolutions of 2.16-3.31Å (Figure 4.4). The best crystal belonged to the 
Index screen condition number 39 (0.1 M HEPES pH 7.0, 30% v/v Jeffamine ED-2001 pH 7.0).  
Data was collected at 100K at the NE-CAT beamline at the Advanced Photon Source 
(APS), Argonne, IL, USA. The crystals diffracted to 2.381 Å. Data was indexed, integrated and 
scaled using iMosflm package program. The crystals belonged to R3: H space group and the unit 
cell dimensions were a=117.359 Å, b=117.359 Å, c=70.898 Å and α=90.000, β=90.000, 
γ=120.000 (Table 4.1). The overall multiplicity was 6.4 with 99.66% data completion. The 
structure was solved using an automated experimental phasing program, that is a part of 
PHENIX. Experimental phases were calculated using Phaser and improved by density 
modification using RESOLVE. After obtaining density modified phases the program carries out 




building were carried out in COOT. Waters were added to the structure using PHENIX and the 
model has a Rwork/Rfree of 18.39/24.9 (Table 4.2-4.3).  
 Crystal structures of the AMP bound complex of Ct-Rio2 were obtained. However, no 
ADP was observed in the active site of the enzyme. Surprisingly, the Ct-Rio2 was bound to AMP 
in the active site. This could be due to the hydrolysis of the ADP to AMP before the crystals 
were formed. We thought this issue could have occurred because of the pH of the solution. 
Testing the pH of the original solutions that were used to set up crystal screening trays showed 
that the pH was as low as 5.4.  
 In the next procedure, 1M Hepes buffer at pH of 7 was used to set the pH of the original ADP 
solution to 7. Subsequently, the newly prepared ADP was incubated with Ct-Rio2 for one hour in the ice. 
This protein solution was then, subjected to robotic sparse matrix screening using Phoenix Liquid 
Handing System again. Commercially available matrix screens were used including Qiagen’s PEG Suite, 
Hampton’s Index Screen, Emerald Biosystems Wizard I, II, and III Screens, Hampton Research’s Natrix 
Screen and Qiagen’s Cryos Suite. Similarly, initial crystal screening was performed in 96 well plates with 
three different proteins to well solution ratios (1:2, 1:1, 2:1). The protein was co-crystallized with ADP at 
pH 7, BeCl2 and KF. The crystals that we obtained in the new procedure were of less resolution of 2.67 Å 
(Figure 4.5).  
4.5.1 Data Collection and Structure Determination 
Data was collected at 100K at the NE-CAT beamline at the Advanced Photon Source 
(APS), Argonne, IL, USA. Data was indexed, integrated and scaled using HKL2000 package 
program. The crystals with the AMP bound in the active site belonged to the R3 space group and 
the unit cell dimensions were a=119.658 Å, b=119.658 Å, c=72.342 Å and α=90.000, β=90.000, 
γ=120.000 (Table 4.4). The structure was solved using PHENIX. After several rounds of 




overall multiplicity was 2.9 with 98.10% data completion. The final model had a Rwork/Rfree of 
19.23/27.24 (Table 4.5-4.6).  
Although crystals were grown with Ct-Rio2 in presence of ADP and MgCl2 and 
BeCl2/KF again the ADP couldn’t be observed and the refined crystal structure didn’t show any 
trace of BeCl2/KF in the active site. Instead the ADP was cleaved to AMP and the protein was 
again bound to AMP in the structure (Figure 4.6). 
  4.6 Crystallization of Ct-Rio2 in Presence of ADP/Na2VO4 
 For the Ct-Rio2/ADP/Vanadate complex, we obtained the diffraction data sets at 7 
conditions with resolutions of 2.02-3.0Å (Figure 4.7). The best crystal belonged to the Natrix 
screen condition number 43 (0.05 M Ammonium acetate, 0.01 M Magnesium chloride 
hexahydrate,0.05 M TRIS hydrochloride pH 7.5, 10% v/v (+/-)-2-Methyl-2,4-pentanediol) at 
2.07 Å resolution. 
4.6.1 Data collection and Structure Determination  
Data was indexed, integrated and scaled using HKL2000 package program. The crystals 
belonged to R3 space group and the unit cell dimensions were a= 118.402 Å, b= 118.402 Å, c= 
72.43 Å and α=90.000, β=90.000, γ=120.000 (Table 4.7). The structure was solved using 
PHENIX. The initial model was first subjected to two rounds of molecular replacement using 
phaser that is part of PHENIX. Subsequent rounds of model building were carried out in COOT 
accompanied by several rounds of refinement using phenix-refine. Waters were added to the 
structure using PHENIX. The overall multiplicity was 3.6 with 99.93% data completion. The 
final model had a Rwork/Rfree of 20.17/25.11 (Table 4.8). 
 Although crystals were grown with CT-Rio2 in presence of ADP, MgCl2 and sodium 




Instead the ADP was again cleaved to AMP and the protein was bound to AMP in the structure. 
Again, contact was observed between the AMP α-phosphate and Asp257and Mg2+ (Figure 4.8). 
4.6.2 Crystallization of Ct-Rio2 in Presence of ADP/VO4 at pH 7 
 These findings were odd and therefore, we thought the cleavage could be due to the 
acidic pH of the droplets. Nucleotides such as ATP and ADP are unstable at lower pH and tend 
to release inorganic phosphate. Therefore, new crystal screenings were performed while the pH 
of the solutions was monitored to be at 7.  The crystals were also grown in a hanging drop screen 
to make larger crystals. Crystals didn’t grow in the new buffer when pH was set to 7 and the only 
crystal that was formed grew large enough for X-ray diffraction studies after 3 weeks at 20°C. 
The crystal was sent for data collection and it diffracted to 3.25 Å (Figure 4.9).   
4.6.3 Data collection and structure determination  
 Data was indexed, integrated and scaled using HKL2000 package program. The crystals 
belonged to R3 space group and the unit cell dimensions were a= 119.252 Å, b= 119.252 Å, c= 
72.75 Å and α=90.000, β=90.000, γ=120.000 (Table 4.9). The structure was solved using 
PHENIX. Subsequent rounds of model building were carried out in COOT accompanied by 
several rounds of refinement using phenix-refine. Waters were added to the structure using 
PHENIX. The new crystals with CT-Rio2 in presence of ADP, MgCl2 and sodium orthovanadate 
did show ADP in the active site.  
 The crystal structure of Ct-Rio2 showed a bilobal kinase domain (green and yellow) 
connected to a N-terminal winged helix domain (pink). The “hinge” region connects the N- and 
C- terminal lobes of the kinase domain. The ADP binding loop “P-loop”, metal binding loop 
used to bind Mg, and catalytic loop which contains the catalytic D232 are indicated by arrows 




 The overlay of the C-Terminal domain in the crystal structures of Ct-Rio2 bound to 
sodium orthovanadate showed that the winged region was not superimposed perfectly and the 
presence of ADP opened up the phosphate binding loop. Crystal structure of Ct-Rio2 at pH 7 
shows the vanadate and ADP in the active site bound to the Asp257 and Mg2+. The aspartate257 
seems to be binding to both VO4 and Mg2+ through H-bonding interactions. In the bilobal kinase 
domain of Ct-Rio2 at pH 5.4, AMP is bound with no trace of VO4 in its active site. The winged 
helix domain of the two structures is not completely superimposed. The overlay of the AMP 
region in the crystal structures of Ct-Rio2 bound to AMP and ADP at two different pH showed 
that both C and N terminal lobes were apart. The overlay of the active site of Ct-Rio2 bound to 
ADP and Orthovanadate vs. Ct-Rio2 bound to AMP displays a dramatic movement of Asp257 
from the AMP bound complex to the vanadate bound complex. 
 4.7 Summary   
Ct-Rio2 was expressed and purified on His TrapTM, QTM column and size exclusion 
column. Success was achieved by overloading the His TrapTM column to remove major protein 
contaminants and degradation products. TEV cleavage was optimized to cleave most of the Ct-
Rio2 in solution by adding 1mg/ml TEv for each 1 mg/Ml od the protein. Passing of Ct-Rio2 
over the His TrapTM a second time after TEV cleavage, removed the remaining contaminants. Ct-
Rio2 was next purified on a QTM column to remove non-specifically bound RNA that could 
impede its crystallization. Following this procedure, the cleaved protein was further purified by 
size exclusion chromatography one day before setting up the crystal screening trays using a 
Superdex 200 column (GE healthcare). Crystals of Ct-Rio2 were then obtained in presence of 










Ct-Rio2 construct:  
N´---6x His Tag--- TEV Site--- Ct-Rio2---C´ 
 Figure 4.1 Schematic representation of Ct-Rio2 construct: Ct-Rio2 construct is 


















                  








 Figure 4.2 Purification of Ct-Rio2 on His TrapTM Column: Supernatant containing 
overexpressed Ct-Rio2 was passed over one His TrapTM column. The SDS-PAGE gels, stained 
with Coomassie Blue, is labeled with lysate (Lys), supernatant (Sup), and flow through (FT) the 
fraction numbers 1-7 that represent 30 mM imidazole concentration and 9-13 represent 50 mM 
imidazole at which the fractions eluted. Ct-Rio2 begins to elute from the His TrapM column at 30 





















         Figure 4.3 Preparative gels after size exclusion chromatography: Lane M is the protein 























       Figure 4.4 The Ct-Rio2 crystals formed in the presence of ADP/BeCl2/KF in the 
hanging drop at pH 5.4: The crystals were produced in 0.1M HEPES pH 7.0., and 30% v/v 














Table 4.1 Data collection and current refinement statistics for AMP-bound Ct-Rio2 at the 
pH 5.4. 
 
Resolution range (Å)                         58.15 - 2.381 (2.466 - 2.381) 
Space group                                       R 3: H 
Unit cell                                              117.359 117.359 70.898 90 90 120 
Total reflections                                  93647 (9349) 
Unique reflections                              14540 (1445) 
Multiplicity                                           6.4 (6.5) 
Completeness (%)                              99.66 (99.31) 
Mean I/sigma (I)                                  19.16 (1.75) 
Wilson B-factor                                   47.84 
R-merge                                              0.08204 (1.2) 
R-meas                                               0.08926 
CC1/2                                                  0.999 (0.553) 
CC*                                                     1 (0.844) 
R-work                                                0.1839 (0.2601) 
R-free                                                  0.2409 (0.3324) 
Number of non-hydrogen atoms         2573 
Macromolecules                                 2541 
Ligands                                               32 
Protein residues                                  343 
RMS (bonds)                                        0.009 
RMS (angles)                                      1.33 
Ramachandran favored (%)               95 
Ramachandran outliers (%)                2.1 
Clash score                                         8.36 
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Table 4.2 AMP bound Ct-Rio2 Scalepack Logfile at pH 5.4. The Ct-Rio2 crystals were 
formed in the presence of ADP/BeCl2/KF in the hanging drop. The crystals were produced in 
0.1M HEPES pH 7.0. 30% v/v jeffamine ED-2001 pH 7.0 at the 2:1 protein to well solution 
ratio.  
 
                                                                       Overall          InnerShell      OuterShell 
Low resolution limit                                            59.23                59.23             1.83 
High resolution limit                                           1.80                  9.88               1.80 
Rmerge  (within I+/I-)                                         1.122                0.116             84.243 
Rmerge  (all I+ and I-)                                        0.280                0.040             21.537 
Rmeas (within I+/I-)                                            1.586                0.164             119.137 
Rmeas (all I+ & I-)                                              0.396                0.057             30.458 
Rpim (within I+/I-)                                              1.122                0.116             84.243 
Rpim (all I+ & I-)                                                0.280                0.040              21.537 
Rmerge in top intensity                                       0.073                   -                     -  
Total number of observations                              161653              1170               6709 
Total number unique                                            91794               612                4021 
Mean((I)/sd(I))                                                     20.7                  34.1                1.2 
Mn(I) half-set correlation CC(1/2)                       0.919                0.982             -0.030 
Completeness                                                       87.4                  97.6               77.9 
Multiplicity                                                          1.8                    1.9                  1.7 
Anomalous completeness                                    55.8                  86.1                40.6 
Anomalous multiplicity                                       0.6                    0.9                  0.5 
DelAnom correlation between half-sets              0.000                0.000               0.000 















Table 4.3 AMP-bound Ct-Rio2 phenix.xtriage logfile at pH 5.4. The Ct-Rio2 crystals were 
formed in the presence of ADP/BeCl2/KF in the hanging drop. The crystals were produced in 
0.1M HEPES pH 7.0. 30% v/v jeffamine ED-2001 pH 7.0 at the 2:1 protein to well solution 
ratio.  
------------------------------------------------------------------------------------------------ 
| Res. Range   | I/sigI>1  | I/sigI>2  | I/sigI>3  | I/sigI>5  | I/sigI>10 | I/sigI>15 | 
------------------------------------------------------------------------------------------------ 
| 58.18 - 4.72 | 99.7%     | 99.4%     | 98.9%     | 97.5%    | 95.1%     | 92.1%      
|  4.72 - 3.75  | 99.8%     | 98.5%     | 97.2%     | 94.8%    | 88.6%     | 80.6%      
|  3.75 - 3.27  | 99.0%     | 95.5%     | 91.9%     | 84.2%    | 70.7%     | 56.7%      
|  3.27 - 2.97  | 96.8%     | 89.1%     | 81.5%     | 67.4%    | 42.0%     | 26.6%      
|  2.97 - 2.76  | 93.4%     | 76.0%     | 62.6%     | 42.9%    | 17.6%     | 8.4%       
|  2.76 - 2.60  | 89.6%     | 62.9%     | 45.6%     | 24.5%    | 6.4%       | 2.0%       
|  2.60 - 2.47  | 85.4%     | 48.0%     | 28.0%     | 12.1%    | 2.5%       | 0.9%       
|  2.47 - 2.36  | 81.5%     | 38.1%     | 18.4%     | 6.5%      | 0.6%       | 0.8%      
|  2.36 - 2.27  | 76.3%     | 29.1%     | 11.3%     | 2.4%      | 0.2%       | 0.0%       
|  2.27 - 2.19  | 72.9%     | 20.6%     | 5.3%       | 1.1%      | 0.3%       | 0.0%       
|  2.19 - 2.12  | 67.9%     | 14.1%     | 3.1%       | 0.3%      | 0.0%       | 0.0%      
|  2.12 - 2.06  | 63.7%     | 10.5%     | 1.0%       | 0.0%      | 0.0%       | 0.0%       
|  2.06 - 2.01  | 60.6%     | 8.5%       | 0.5%       | 0.0%      | 0.0%       | 0.0%       
|  2.01 - 1.96  | 48.6%     | 5.2%       | 0.3%       | 0.0%      | 0.0%       | 0.0%       
----------------------------------------------------------------------------------------------- 
  The completeness of data for which I/sig(I)>3.00, exceeds  85% 











       Figure 4.5 The CtRio2 crystals formed in the presence of ADP/BeCl2/KF in the 
hanging drop at pH 7: The crystals were produced in 0.1M HEPES pH 7.0. 30% v/v jeffamine 


















Table 4.4 Data collection and current refinement statistics for AMP-bound Ct-Rio2 at the 
pH of 7. The Ct-Rio2 crystals were formed in the presence of ADP/BeCl2/KF in the hanging 
drop. The crystals were produced in 0.1M HEPES pH 7.0. 30% v/v jeffamine ED-2001 pH 7.0 at 
the 2:1 protein to well solution ratio. 
 
Resolution range (Å)                               59.83 - 2.67 (2.766  - 2.67) 
Space group                                             R 3 :H 
Unit cell                                                  119.658 119.658 72.342 90 90 120 
Total reflections                                      31595 (3181) 
Unique reflections                                  10772 (1101) 
Multiplicity                                             2.9 (2.9) 
Completeness (%)                                   98.10 (97.83) 
Mean I/sigma (I)                                     6.08 (0.39) 
Wilson B-factor                                      69.38 
R-merge                                                  0.1973 (2.943) 
R-meas                                                    0.2448 
CC1/2                                                      0.98 (0.0356) 
CC*                                                         0.995 (0.262) 
R-work                                                    0.1923 (0.3031) 
R-free                                                      0.2724 (0.4227) 
Number of non-hydrogen atoms             2573 
Macromolecules                                     2541 
Ligands                                                   32  
Protein residues                                      343 
RMS (bonds)                                          0.010 
RMS (angles)                                         1.42 
Ramachandran favored (%)                   91 
Ramachandran outliers (%)                   3.3 
Clash score                                            11.03 










59.83 - 2.67 (2.766 - 2.67) 
R 3: H 


























Table 4.5 AMP bound Ct-Rio2 Scalepack Logfile at pH 7. The Ct-Rio2 crystals were formed 
in the presence of ADP/BeCl2/KF in the hanging drop. The crystals were produced in 0.1M 
HEPES pH 7.0. 30% v/v jeffamine ED-2001pH 7.0 at the 2:1 protein to well solution ratio.  
                                                         Overall  InnerShell  OuterShell 
Low resolution limit                                      59.49     59.49      3.44 
High resolution limit                                      3.26     10.31      3.26 
Rmerge  (within I+/I-)                                     0.110     0.020     0.907 
Rmerge  (all I+ and I-)                                    0.127     0.025     1.027 
meas (within I+/I-)                                          0.141     0.026     1.160 
Rmeas (all I+ & I-)                                         0.143     0.028     1.154 
Rpim (within I+/I-)                                         0.087     0.016     0.717 
Rpim (all I+ & I-)                                           0.065     0.013     0.520 
Rmerge in top intensity bin                                   0.021        -         -  
Total number of observations                       28637       902      4148 
Total number unique                                      5955       188       862 
Mean((I)/sd(I))                                               13.0      56.4       1.7 
Mn(I) half-set correlation CC(1/2)                0.996     0.999     0.564 
Completeness                                                  99.9      98.9     100.0 
Multiplicity                                                     4.8       4.8       4.8 
Anomalous completeness                                93.8      95.4      92.9 
Anomalous multiplicity                                  2.3       2.4       2.3 
DelAnom correlation between half-sets            0.058     0.200     0.023 
Mid-Slope of Anom Normal Probability         1.063       -         -   
Average unit cell                                               119  119 72.35 90 90 120 
Space group 



















59.49       59.49      3.44 
3.26         10.31      3.26 
0.110       0.020     0.907 
0.127       0.025     1.027 
0.141       0.026     1.160 
0.143       0.028     1.154 
0.087       0.016     0.717 
0.065       0.013     0.520 
0.021        -             -  
28637      902        4148 
5955        188        862 
13.0         56.4       1.7 
0.996       0.999     0.564 
99.9         98.9       100.0 
4.8           4.8         4.8 
93.8         95.4       92.9 
2.3           2.4         2.3 
0.058       0.200     0.023 
1.063         -            -   






Table 4.6 AMP-bound Ct-Rio2 phenix.xtriage logfile at pH 7. The Ct-Rio2 crystals were 
formed in the presence of ADP/BeCl2/KF in the hanging drop. The crystals were produced in 
0.1M HEPES pH 7.0. 30% v/v jeffamine ED-2001 pH 7.0 at the 2:1 protein to well solution 
ratio.  
 
Res. Range   | I/sigI>1  | I/sigI>2  | I/sigI>3  | I/sigI>5  | I/sigI>10 | I/sigI>15 | 
---------------------------------------------------------------------------------------------- 
| 59.49 - 7.69 | 98.3%     | 97.6%    | 97.0%     | 69.5%     | 0.0%      | 0.0%       
|  7.69 - 6.10 | 98.4%     | 96.7%     | 91.3%     | 63.7%     | 0.0%      | 0.0%       
|  6.10 - 5.33 | 97.7%     | 93.7%     | 84.8%     | 50.1%     | 0.0%      | 0.0%       
|  5.33 - 4.84 | 97.8%     | 91.8%     | 82.0%     | 43.2%     | 0.0%      | 0.0%       
|  4.84 - 4.50 | 98.3%     | 90.9%     | 77.7%     | 41.6%     | 0.0%      | 0.0%       
|  4.50 - 4.23 | 97.8%     | 86.9%     | 73.8%     | 38.0%     | 0.0%      | 0.0%       
|  4.23 - 4.02 | 96.7%     | 84.5%     | 67.3%     | 26.8%     | 0.0%      | 0.0%       
|  3.84 - 3.70 | 96.1%     | 73.7%     | 53.4%     | 14.3%     | 0.0%      | 0.0%       
|  3.70 - 3.57 | 93.8%     | 68.2%     | 44.1%     | 13.2%     | 0.0%      | 0.0%       
|  3.57 - 3.46 | 90.6%     | 53.2%     | 30.7%     | 6.7%       | 0.0%      | 0.0%       
|  3.46 - 3.36 | 87.9%     | 43.4%     | 22.1%     | 3.0%       | 0.0%      | 0.0%       
|  3.36 - 3.27 | 81.8%     | 38.9%     | 18.6%     | 1.5%       | 0.0%      | 0.0%       
























 Figure 4.6 Alignment between bound AMP to CtRio2 at both pH 5.2 and pH 7.0: 
The structures of Ct-Rio2 are aligned based on the AMP location. The orientation of Asp 257 is 

















      Figure 4.7 The Ct-Rio2 crystals formed in the presence of ADP/Na2VO4 in the hanging 
drop at pH 5.4: The crystals were produced with 0.05M ammonium acetate, 0.01 magnesium 






















Table 4.7 Data collection and current refinement statistics for AMP-bound Ct-Rio2 at the 
pH 5.4: The Ct-Rio2 crystals formed in the presence of ADP/Na2VO4 in the hanging drop at pH 
5.4: The crystals were produced with 0.05M ammonium acetate, 0.01 magnesium chloride, 
0.05M TRIS hydrochloride pH 7.5, 10% v/v 2-methyl-2,4-pentandiol.  
 
Resolution range (Å)                                          59.2 - 2.07 (2.144 - 2.07) 
Space group                                                        R 3: H  
Unit cell                                                              118.402 118.402 72.43 90 90 120 
Total reflections                                                 56005 (1547) 
Unique reflections                                              23038 (809) 
Multiplicity                                                         3.6 (1.9) 
Completeness (%)                                               99.93 (99.65) 
Mean I/sigma (I)                                                 5.80 (0.65) 
Wilson B-factor                                                  50.83 
R-merge                                                              0.7257 (1.091) 
R-meas                                                                0.8069 
CC1/2                                                                  0.99 (0.441) 
CC*                                                                     0.997 (0.782) 
R-work                                                                0.2017 (0.2774) 
R-free                                                                  0.2511 (0.3206) 
Number of non-hydrogen atoms                         2567 
Macromolecules                                                  2543 
Ligands                                                                24 
Protein residues                                                  338 
RMS (bonds)                                                       0.014 
RMS (angles)                                                      1.59 
Ramachandran favored (%)                                 93 
Ramachandran outliers (%)                                 2.1 
Clashscore                                                           4.82 



















Table 4.8 AMP-bound Ct-Rio2 phenix.xtriage logfile at the pH 5.4: The Ct-Rio2 crystals 
formed in the presence of ADP/Na2VO4 in the hanging drop at pH 5.4: The crystals were 
produced with 0.05M ammonium acetate, 0.01 magnesium chloride, 0.05M TRIS hydrochloride 
pH 7.5, 10% v/v 2-methyl-2,4-pentandiol.  
---------------------------------------------------------------------------------------- 
| Res. Range   | I/sigI>1  | I/sigI>2  | I/sigI>3  | I/sigI>5  | I/sigI>10 | I/sigI>15 | 
---------------------------------------------------------------------------------------- 
| 59.24 - 4.28| 99.9%     | 99.8%     | 99.5%     | 98.0%     | 79.3%     | 51.3%      
|  4.28 - 3.39 | 99.9%     | 99.6%     | 99.0%     | 97.2%     | 88.4%     | 67.9%      
|  3.39 - 2.97 | 99.5%     | 97.7%     | 95.8%     | 91.3%     | 72.8%     | 42.3%     
|  2.97 - 2.69 | 99.1%     | 93.7%     | 89.0%     | 78.5%     | 47.2%     | 19.8%     
|  2.69 - 2.50 | 97.1%     | 85.5%     | 76.3%     | 59.4%     | 24.7%     | 8.0%       
|  2.50 - 2.35 | 94.4%     | 76.8%     | 63.1%     | 41.8%     | 10.1%     | 2.0%       
|  2.35 - 2.24 | 90.8%     | 65.8%     | 48.0%     | 24.3%     | 3.8%       | 0.6%       
|  2.24 - 2.14 | 87.6%     | 52.1%     | 31.4%     | 11.5%     | 1.0%       | 0.1%       
|  2.14 - 2.06 | 80.1%     | 34.2%     | 15.1%     | 3.1%       | 0.2%       | 0.0%       
|  2.06 - 1.99 | 74.0%     | 22.8%     | 7.5%       | 1.1%       | 0.1%       | 0.0%       
|  1.99 - 1.92 | 66.3%     | 13.9%     | 2.8%       | 0.6%       | 0.0%       | 0.0%       
|  1.92 - 1.87 | 59.8%     | 9.1%       | 1.0%       | 0.0%       | 0.0%       | 0.0%       
|  1.87 - 1.82 | 56.5%     | 5.8%       | 0.5%       | 0.0%       | 0.0%       | 0.0%      
|  1.82 - 1.77 | 49.3%     | 4.2%       | 0.3%       | 0.0%       | 0.0%       | 0.0%       
---------------------------------------------------------------------------------------- 
 















 Figure 4.8 Crystal Structure of AMP bound Ct-Rio2: The crystal structure of Ct-Rio2 
shows a bilobal kinase domain (green and orange) connected to an N-terminal winged helix 













      Figure 4.9 The Ct-Rio2 crystals formed in the presence of ADP/Na2VO4 in the hanging 
drop at pH 7.0: The crystals were produced in 0.05M ammonium acetate, 0.01 magnesium 











Table 4.9 AMP-bound Ct-Rio2 Scalepack Logfile at pH 7. The Ct-Rio2 crystals formed in the 
presence of ADP/Na2VO4 in the hanging drop at pH 5.4: The crystals were produced in 0.05M 
ammonium acetate, 0.01 magnesium chloride, 0.05M TRIS hydrochloride pH 7.5, 10% v/v 2-
methyl-2,4-pentandiol.  
 
Resolution range (Å)                           59.48 - 3.252 (3.369  - 3.252) 
Space group                                        R 3: H 
Unit cell                                              119.252 119.252 72.75 90 90 120 
Total reflections                                  22654 (1412) 
Unique reflections                               6037 (522) 
Multiplicity                                          3.8 (2.7) 
Completeness (%)                               99.47 (99.84) 
Mean I/sigma (I)                                 1.12 (0.13) 
Wilson B-factor                                  89.46 
R-merge                                              0.8686 (3.86) 
R-meas                                                0.9781 
CC1/2                                                  0.967 (0.477) 
CC*                                                     0.992 (0.804) 
R-work                                                0.1737 (0.3155) 
R-free                                                  0.2654 (0.2951) 
Number of non-hydrogen atoms         2731 
Macromolecules                                  2695 
Ligands                                                36 
Protein residues                                   343 
RMS (bonds)                                       0.013 
RMS (angles)                                      1.70 
Ramachandran favored (%)                86 
Ramachandran outliers (%)                3.6 
Clashscore                                          18.86 














    Figure 4.10 Crystal structure of Ct-Rio2 bound to ADP and transition state analogue 
sodium orthovanadate: The crystal structure of Ct-Rio2 shows a bilobal kinase domain (green 
and yellow) connected to an N-terminal winged helix domain (pink). The “hinge” region 
connects the N- and C- terminal lobes of the kinase domain. The ADP binding loop “P-loop”, 
metal binding loop used to bind Mg, and catalytic loop which contains the catalytic D232 are 










Chapter 5: Structural Analysis of AMP- and ADP-Bound Ct-Rio2 
 5.1 Introduction  
 In the last chapter, I discussed how Ct-Rio2 was purified and how the X-ray diffraction 
data were acquired. In this chapter, I will analyze the structural features of Ct-Rio2. The first 
structure of eukaryotic Rio2 kinases has been found in our lab in Ct-Rio2. This protein is 
significantly extended compared to the archaeal version of Rio2 for which we currently have 
structural information. 
 5.2 Obtaining the Crystal Structure of Ct-Rio2  
 Both apo-ctRio2 crystals and Ct-Rio2 with ATP crystals were solved by molecular 
replacement using the known structure of afRio2 with ADP and Mn2+ bound. Vatsala Sagar 
provided in her study what the apo and ATP-bound Ct-Rio2 looks like. Using the purification 
techniques that were optimized in my work, Ct-Rio2 was crystalized in in the presence of ADP 
and AMP. Our initial goal was to obtain the transition state analogues of Ct-Rio2 in presence of 
BeCl2/KF and Na2VO4. These structures could be interesting since they represent the active site 
scheme of the transfer of Phosphate group from ATP to Asp residue on Ct-Rio2. 
 A previous model of Ct-Rio2 was used for molecular replacement. The program used for 
molecular replacement was the Phaser crystallography software suite in PHENIX. Additionally, 
Refinement was done with phenix.refine in Phaser. Rfree was monitored by using 10% of the 
reflections as a test set. The crystallographic refinement statistics are shown in last chapter along 






 5.3 Crystal Structure of Ct-Rio2 with ADP, BeCl2/KF 
 Crystals of the Ct-Rio2 structure and the ADP, BeCl2 and KF complex were isomorphous 
and belonged to the space group H3, with one molecule per asymmetric unit. Diffraction of the 
complex was measured on a synchrotron source (NE-CAT, Argonne National Laboratories 
Advanced Photon Source). Although Ct-Rio2 was crystallized in the presence of 20 mM ADP 
and 2.5 mM MgCl2 and BeCl2 and KF, no ADP was observed in the active site of the enzyme. 
Details of the crystallization methods were described in Chapter 4. We thought this could have 
happened because the ADP was degraded or that it was not bound to the protein in the crystals. 
We also didn’t observe the Beryllium complexes in the crystal.  
 However, as discussed in the last chapter, the AMP was found in the crystal in both 
conditions when the BeCl2, KF, and ADP were added at both pH of 5.4 and pH of 7. This 
observation especially at pH 7 can mean that Ct-Rio2 can be capable of performing ADPase 
activity as well as being an ATPase. This hypothesis could be less probable that meaning that the 
ADP molecule is not stable in presence of BeCl2 and KF. The latter is more convincing since we 
have observed previously in the ATP bound protein and in the last chapter when vanadate was 
used that ADP can bind to the protein and is not degraded at pH 7.  
 5.4 The Structural Analysis of the AMP-Bound Ct-Rio2 
 The structural features of the AMP-bound Ct-Rio2 were very similar to what has been 
observed previously in the ATP-bound Ct-Rio2 structure (Figure 5.1). The N-terminus of Ct-
Rio2 bound to the AMP contains a winged helix domain. It is comprised of four α helices 
followed by a β-strand wing β-strand motif, and another α helix. The Rio domain in Ct-Rio2 
consists of an N-terminal lobe and a C-terminal lobe with a flexible hinge region between them. 




 The N-terminal lobe consists of a five-stranded antiparallel β sheet and a long α helix. 
The C-terminal lobe of the RIO domain consists of two antiparallel β strands and two α helices. 
The third α helix seen in af-Rio2 is missing in the Ct-Rio2 structure. However, instead there is 
another C-terminal α helix that is not seen in the af-Rio2 structure partially obstructing the 
opening to the active site. This α helix, labeled αJ, is situated in the cleft between the C and N 
terminal lobes of the RIO kinase domain.  
 The active site of Ct-Rio2 contains three loops—the P-loop, the “DFG” loop, and the 
catalytic loop. The P-loop is involved in binding AMP and orienting the phosphate in a position 
to be attacked by the nucleophilic serine in a phosphoryl transfer reaction. The “DFG” loop binds 
and positions the metal ions that coordinate the phosphate oxygens of AMP and help orient the 
nucleotide. The catalytic loop contains the conserved N and D residues necessary for catalysis 
and metal binding. In typical protein kinases the sequence of the P-loop is GXGXXG. In Ct-Rio2 
the sequence is GVGKES. The sequence of the DFG loop in Ct-Rio2 is IDFPQ and the catalytic 
loop sequence is DLSQYN (Figure 5.3).   
 Polar contacts could be observed between the α-phosphate of AMP and Mg2+ with 
Met166, Ser108, Asp257 and Asn234. This structure was perfectly fit in the 2Fo-Fc map of Ct-
Rio2 (Figure 5.4). 
 5.5 Crystal Structure of Ct-Rio2 in the Presence of ADP and Na2VO4 
 For the Ct-Rio2/ADP/Vanadate complex, we obtained the diffraction data sets at 3.25 Å. 
Data was indexed, integrated and scaled using HKL2000 package program. The crystals 
belonged to R3 space group and the unit cell dimensions were a= 119.252 Å, b= 119.252 Å, c= 
72.75 Å and α=90.000, β=90.000, γ=120.000. Crystal structure of Ct-Rio2 at pH 7 shows the 




polar interaction to both VO4 and Mg2+. The overlay of the active site of Ct-Rio2 bound to ADP 
and Orthovanadate vs. Ct-Rio2 bound to AMP displays a dramatic movement of Asp257 from 
the AMP bound complex to the vanadate bound complex (Figure 5.5-5.6). 
 5.6 Summary  
 The crystal structure of Ct-Rio2 was determined and the structures of AMP and 
ADP/VO4 bound Ct-Rio2 were compared. In both of the structures the Ct-Rio2 protein showed a 
bilobal structure that was expected. In the AMP bound protein the Asp257 bonded the α-
phosphate of the AMP in a different location and orientation compared to that of the ADP bound 
protein.  
 The movement of asp257 in the transition state analog structure reveals that in the 
presence of the ATP the protein bilobal structure opens up to accommodate the ligand. The 
orientation of Asp257 is then changed to bind the gamma-phosphate of the ATP. In this case the 
vanadate structure mimics the γ-phosphate of the ATP. The structure of Ct-Rio2 in a complex 
with AMP aligns well with the previous apo protein structure. Moreover, Ct-Rio2 as expected 
showed an extended C-terminus containing αJ. The αJ interacts with the kinase domain through 
both hydrophobic and hydrophilic interactions with αC, αF, the flexible loop and the metal 
binding loop.  
 The Asp257 displays to both VO4 and Mg2+ through polar interactions. In the bilobal 
kinase domain of Ct-Rio2 at pH 5.4, AMP is bound with no trace of VO4 in its active site. The 
winged helix domain of the two structures is not completely superimposed. The overlay of the 
AMP region in the crystal structures of Ct-Rio2 bound to AMP and ADP at two different pH 




bound to ADP and Orthovanadate vs. Ct-Rio2 bound to AMP displays a dramatic movement of 










 Figure 5.1 Crystal Structure of AMP bound Ct-Rio2 shows bilobal structure: The 
crystal structure of Ct-Rio2 shows a bilobal kinase domain (green and orange) connected to an 
N-terminal winged helix domain (pink). The “hinge” region connects the N- and C-terminal 
lobes of the kinase domain. The ATP binding loop “P-loop”, metal binding loop used to bind 
Mg, and catalytic loop which contains the catalytic D257 are indicated by arrows. The cartoon 











 Figure 5.2 Crystal Structure of AMP-bound Ct-Rio2: The N-terminus of Ct-Rio2 
contains a winged helix domain. It is comprised of four α helices followed by a β-strand wing β-
strand motif, and another α-helix. AMP binds in the large cleft between the two lobes. The N-
terminal lobe consists of a five-stranded antiparallel β sheet and a long α helix. The C-terminal 

































 Figure 5.3 Polar Contacts with the AMP: Crystal structure of AMP bound Ct-Rio2 



























 Figure 5.4 Alignment between bound AMP to CtRio2 at both pH=5.2 and pH=7.0: 
The structures of Ct-Rio2 are aligned based on the AMP location. The orientation of Asp 257 is 








 Figure 5.5 The active site of Ct-Rio2 bound to ADP and Orthovanadate: The crystal 
structure of Ct-Rio2 with vanadate and ADP shows that polar Contacts can be observed between 
α and β phosphate of ADP with Lys. The β phosphate of ADP is simultaneously bound to 











 Figure 5.6 The overlay of the active site of Ct-Rio2 bound to ADP and 
Orthovanadate vs. Ct-Rio2 bound to AMP: The Asp 257 displays a dramatic movement from 































Chapter 6: Evolution of the Eukaryotic Protein Kinases 
 6.1 Evolutionary Origins of the Eukaryotic Protein Kinases  
 For many years after the discovery of protein phosphorylation, the phosphorylation of 
proteins on serine, threonine, and tyrosine residues was a phenomenon that was thought to be 
restricted to the eukaryotes, in which these modifications perform important regulatory 
functions78. The analogous regulatory role in bacteria was attributed to the sensor kinases and the 
phosphoenolpyruvate-dependent phosphotransferase systems, which typically catalyze the 
phosphorylation of proteins on histidine and aspartate residues, respectively. Later on the 
observation of proteins containing phosphoserine, phosphothreonine, or phosphotyrosine 
residues in bacteria and archaea illustrated that several mechanisms of Ser/Thr or Tyr protein 
phosphorylation have been recognized in prokaryote79.  
 6.2 The Rio Family  
 In order to examine the evolutionary origins of the eukaryotic protein kinase (ePK) 
superfamily, extensive analysis has been conducted over the past years on the proteins encoded 
by the completely sequenced bacterial and archaeal genome80. Five distinct families of putative 
protein kinases are detected with representatives in bacteria and archaea that share a common 
ancestry with the eukaryotic protein kinases. Except Rio proteins the other four of these protein 
families have not been identified previously as protein kinases. From the phylogenetic 
distribution of these families, the existence of an ancestral protein kinase(s) prior to the 
divergence of eukaryotes, bacteria, and archaea is predicted81. Most of the eukaryotes and 
archaea contain two paralogs of the Rio family. These proteins form two (or possibly three) 




the reversible protein phosphorylation which is mainly responsible for cellular regulation and 
signal transduction in all three domains of life. Since any abnormal levels of phosphorylation is 
known to be responsible for variety of sever diseases, there’s a considerable therapeutic promise 
in obtaining a detailed understanding of phosphorylation processes, both within a specific cell 
and in their evolutionary context80.  
 6.3 The Common Classifications of Protein Kinases  
 Based on the KinBase resource, protein kinases are classified into two broad groups of 
conventional eukaryotic protein kinases (ePKs) and atypical protein kinases (aPKs)80. By 
examining the sequences and the catalytic domains and considering the known modes of 
regulation, ePKs are subdivided into eight families. The eight ePK families are: the AGC family, 
the CAMKs, the CK1 family, the CMGC family, the RGC family, the STE family, the TKfamily 
and the TLK family50, 82.  
 The aPKs are a smaller set of protein kinases that have shown the protein kinase activity 
but do not share sequence similarities with ePKs. The aPKs are comprised of the following 
subfamilies: alpha, PIKK, PHDK, RIO, BRD, ABC1 and TIF1. In order to examine the 
evolutionary origins of the eukaryotic protein kinase superfamily, Koonin et al have conducted 
an extensive analysis of the proteins encoded by the completely sequences bacterial and archaeal 
genomes. From the phylogenetic distribution of the resulted protein families, the existence of an 
ancestral protein kinase is proposed that existed prior to divergence of eukaryotes, bacteria and 
archaea.  
 Rio kinases were originally identified in Archaea and Eukarya and a common ancestor 
with an ancestral Rio gene has been predicted. Phylogenetic analysis has revealed that Rio 




including: Rio1, Rio2, Rio3 and RioB.  Rio2 exist in archaea, eukaryotes and bacteria with high 
sequence and activity similarities. Canonical protein kinases are only observed in archaea. 
Canonical protein kinases are very similar to Rio2 proteins but are more active in ATPase and 
autophosphorylation activity79.  
 Computational studies have revealed that the arginine residue at position 228 highly 
affects the activity of canonical protein kinases. This residue in Rio family is replaced by either 
alanine or glycine.  
 In this study, we are interested to study mutation at 228 of Rio2, and find out how this 
mutation would affect the structure and activity of the Rio2 family. We are interested to 
investigate the evolutionary relationship between Rio kinases and the canonical eukaryotic 
protein kinases. Our hypothesis is that canonical eukaryotic protein kinases have evolved from 
Rio kinases. We have made several mutations in a key differentiating position of the kinase 
domain sequence of Ct-Rio2, G228, and have collected biochemical data to test the ability of the 
mutated Rio kinase to autophosphorylate and carry out ATP hydrolysis.  
 6.4 Purification of Rio2 Mutants from Chaetomium Thermophilum  
 Following the optimized procedure outlined in chapter 2 Ct-Rio2 mutants were designed 
and were further expressed, purified and crystallized. The p7-Ct-Rio2 vectors were transformed 
into E. coli RosettaTM(DE3) pLysS (Novagen), and were used to perform test expression of the 
cells before purifying large amount of protein. The result of test expression gel revealed that cells 
with the mutants could produce a band of Ct-Rio2 at 44.6kDa (Figure 6.1-6.2).  
 6.5 Crystallization of Ct-Rio2 Mutants 
 We have also co-crystallized Ct-Rio2 G228 point mutants with ATP in order to 




same procedure that was developed for wild type Ct-Rio2, five mutants of Ct-Rio2 were purified 
and co-crystalized with ATP/Mg2+. These mutants included G228A, G228D, G228N, G228R, 
and G228V. While it was difficult to obtain any crystals for G228R and G228V, several crystals 
were formed for the G228A, G228D, and G228N mutants and x-ray diffraction data sets were 
collected (Figure 6.3).  
 The best crystals for G228A belonged to the Wizard screen condition number 70 (10% 
(v/v) 2-propanol, 0.1M imidazole pH 8.0). For G228D the best hit belonged to PEG condition 40 
(0.2 M Sodium phosphate dibasic dehydrate, 20% w/v Polyethylene glycol 3,350) and for 
G228N belonged to Wizard screen number 66 (20% (w/v) PEG-3000. 0.1M Tris pH 7.0, 0.2M 
Ca(OAc)2). The crystal structure of Ct-Rio2 with Asn mutation at residues 228 shows a bilobal kinase 
domain (blue and yellow) connected to N-terminal winged helix domain (green). The “hinge” region 
connects the N- and C- terminal lobes of the kinase domain. 
 6.6 Crystal Structure of AMP Bound G228N 
 Data was indexed, integrated and scaled using HKL2000 package program. The crystals 
belonged to R3 space group and the unit cell dimensions were a=118.623 Å, b=118.623 Å, 
c=72.556 Å and α=90.000, β=90.000, γ=120.000 (Table 6.1). The structure was solved using 
PHENIX. Subsequent rounds of model building were carried out in COOT accompanied by 
several rounds of refinement using phenix-refine. Waters were added to the structure using 
PHENIX. The multiplicity was 5.2 and completeness was 99.71. The final model had a 
Rwork/Rfree of 20.03/24.69 (Table 6.1).  
 6.7 Crystal Structure of AMP Bound G228A 
Data was indexed, integrated and scaled using HKL2000 package program. The crystals 




c=72.342 Å and α=90.000, β=90.000, γ=120.000 (Table 6.2). The structure was solved using 
PHENIX. Subsequent rounds of model building were carried out in COOT accompanied by 
several rounds of refinement using phenix-refine. Waters were added to the structure using 
PHENIX. The multiplicity was 2.5 and completeness was 98.10. The final model had a 
Rwork/Rfree of 18.65/25.78 (Table 6.2).  
 6.8 Crystal Structure of AMP Bound G228D 
Data was indexed, integrated and scaled using HKL2000 package program. The crystals 
belonged to R3 space group but the twining was high. Tried deleting few frames in iMOSFLM 
but couldn’t solve the twining issue.  
 6.9 Results and Discussion  
 The crystal structure of Ct-Rio2 G228N, and G228A showed a bilobal kinase domain 
connected to a N-terminal winged helix domain (Figure 6.4-6.5).  
 The overlay of the C-Terminal domain in the crystal structures of G228N and G228A of 
Ct-Rio2 showed that the winged region was not superimposed perfectly and the presence of the 
Asn at the 228 opened up the phosphate binding loop (Figure 6.6). Upon the overlay of the 
bound AMP groups none of the C and N terminal lobes neither the winged helix domain of the 
structures was completely superimposed (Figure 6.7). The overlay of the c-terminal region in the 
crystal structures of G228N, G228A and G228 of Ct-Rio2 bound to AMP showed that while the 
A and wild type Glycine Ct-Rio2 were superimposable the Asn mutated Ct-Rio2 was structurally 
different.  
 6.10 ATPase Activity and Autophosphorylation Comparison 
 Based on our steady state hydrolysis assay results, we have found that the proteins with 




phosphorylation experiments (Figure 6.8). The G228A and Ct-Rio2 with G228 are similarly 
active in the hydrolysis of ATP but mutants with larger residues such as G228V are less active. 
The mutants with charged residues such as those we find mostly in the EPKs5 including G228D 
and G228N and G228R are almost inactive in ATP hydrolysis. In line with our predictions, the 
auto-phosphorylation of G228D and G228N are less pronounced than the other mutations. Our 
crystal structure finds very similar structure for the G228A and G228V mutants to that of Ct-
Rio2 (Figure 6.9).  
 6.11 Summary 
 The procedure that was used for the purification of the mutants was at the pH of 5.4. We 
believe that the ATP that was originally mixed with the protein for crystallization has degraded 
to AMP. But the comparison of the crystal structure of all of the mutants can be studied since all 
of the mutants were bound to AMP. When I overlay the structures based on the AMP in their 
active site or based on the C terminus, the mutant with N at the residue 228 had an active site 
that was wider than that of Glycine and Alanine crystals. This opening of the catalytic loop 
seems to decrease the ATPase activity and at the same time increase the kinase activity and 
autophosphorylation. The same phenomena are observed in the epks. In the canonical epks the 
active site is wide due to the arginine residue at 228. We have observed in our ATPase and 
autophosphorylation experiments that residues that have R or a residue as large as arginine are 
more capable of autophosphorylation. However, the alanine and glycine residues are better as 
ATPases than Kinases. Since the Rio kinases have existed 1.5 billion years before the emergence 
of the cananoical eukaryotic protein kinases, they are very likely to have been the ancestors of 
the epks. This hypothesis is strongly supported based on the sequence alignment studies. This 




to a better autophosphorylation kinase. The core of the epks is very similar to Rio kinases and 
many residues are conserved. The few changed residues and the secondary structures that are 
later added to the canonical protein kinases could have a great impact on their function and 


























 Figure 6.1 Testing of the expression of Ct-Rio2 protain and its G228 mutants in 
E.Coli: The induced (I) samples show a single band at 46 kD which corresponds to Ct-Rio2 and 












           Ct-Rio2     G228A    G228D   G228N                              G228R    G228 V 





          Figure 6.2 Preparative gels after size exclusion chromatography: Lane M is the protein 
ladder. Gel of Ct-Rio2 displays pure protein at the expected molecular weight of 44.6 kDa for all 






































Table 6.1 Data collection and current refinement statistics for AMP bound G228N. The Ct-
Rio2 crystals formed in the presence of ATP in the hanging drop at pH=5.4. 
 
Resolution range (Å)                                59.27 - 2.26 (2.341 - 2.26) 
Space group                                              R 3:H 
Unit cell                                                    118.623 118.623 72.556 90 90 120 
Total reflections                                        91917 (9664) 
Unique reflections                                     17775 (1835) 
Multiplicity                                               5.2 (5.3) 
Completeness (%)                                     99.71 (99.67) 
Mean I/sigma(I)                                        17.59 (1.58) 
Wilson B-factor                                        57.85 
R-merge                                                    0.05927 (1.069) 
R-meas                                                      0.066 
CC1/2                                                        0.999 (0.576) 
CC*                                                           1 (0.855) 
R-work                                                      0.2003 (0.2789) 
R-free                                                        0.2469 (0.3160) 
Number of non-hydrogen atoms               2723 
macromolecules                                        269 
ligands                                                       32 
Protein residues                                         343 
RMS(bonds)                                             0.015 
RMS(angles)                                             1.71 
Ramachandran favored (%)                      91 
Ramachandran outliers (%)                      3 
Clashscore                                                16.52 
















Table 6.2 Data collection and current refinement statistics for AMP bound G228A: The Ct-
Rio2 crystals formed in the presence of ATP in the hanging drop at pH=5.4. 
 
 
Resolution range (Å)                                          59.83  - 2.67 (2.766  - 2.671) 
Space group                                                        R 3 :H 
Unit cell                                                              119.658 119.658 72.342 90 90 120 
Total reflections                                                  14453 (329) 
Unique reflections                                              10772 (224) 
Multiplicity                                                         2.5 (1.5) 
Completeness (%)                                               98.10 (97.83) 
Mean I/sigma(I)                                                  9.51 (0.97) 
Wilson B-factor                                                  69.38 
R-merge                                                              0.572 (0.5181) 
R-meas                                                               0.6674 
CC1/2                                                                 0.986 (0.663) 
CC*                                                                    0.996 (0.893) 
R-work                                                               0.1865 (0.3083) 
R-free                                                                 0.2578 (0.4007) 
Number of non-hydrogen atoms                        2587 
macromolecules                                                 2555 
ligands                                                                32 
Protein residues                                                 343 
RMS(bonds)                                                      0.009 
RMS(angles)                                                     1.36 
Ramachandran favored (%)                              90 
Ramachandran outliers (%)                               3 
Clashscore                                                         10.47 







           Figure 6.4 Crystal Structure of AMP bound G228N: The crystal structure of Ct-Rio2 
with Asn mutation at residues 228 shows a bilobal kinase domain (blue and yellow) connected to 
an N-terminal winged helix domain (green). The “hinge” region connects the N- and C-terminal 







         Figure 6.5 Crystal Structure of AMP bound G228A: The crystal structure of Ct-Rio2 
with alanine mutation at residues 228 shows a bilobal kinase domain (green and orange) 
connected to an N-terminal winged helix domain (pink). The “hinge” region connects the N- and 








          Figure 6.6 The overlay of the C-Terminal domain in the crystal structures of G228N 
and G228G (wild type Ct-Rio2): The winged helix domain of the two structures are not 
completely superimposable. The presence of Asn in the structure pushes the winged helix 






           Figure 6.7 The overlay of the AMP domain in the crystal structures of G228N and 
G228G (wild type Ct-Rio2): The N and C terminal lobes of the two structures are not 
completely superimposable. The presence of Asn in the structure pushes the winged helix 






           Figure 6.8 The overlay of the C-Terminal domain in the crystal structures of G228N, 
G228A and G228G (wild type Ct-Rio2): The winged helix domain of the G228A and G228 are 
very close to each other compared to the G228N. The presence of Asn in the structure seems to 











        Figure 6.9 The proteins with different point mutations at 228, show very different 
activities in their A) ATPase and B) Auto-phosphorylation experiments: The G228A and Ct-
Rio2 with G228 are similarly active in the hydrolysis of ATP but mutants residues such as those 
mostly observed in epks (G228V, and G228R) are less active. In line with our predictions, the 


















Chapter 7: Conclusion and Future Work 
 7.1 Crystal Structure of EspB  
 In chapter two of this dissertation, the purification and crystallization procedure of EspB 
is explained in detail. We optimized purification of EspB to obtain highly pure protein samples 
that were immediately used for crystallization. In chapter two, the X-ray crystallographic 
structure of the helical domains of EspB from M. Marinum was determined in a crystal form 
encompassing residues 1-292.  
Going back to our objectives that are presented in chapter 1, now we can answer our questions 
about EspB. 
 The molecular structure of EspB  
 The EspB structure is composed of 16 long, antiparallel coiled-coil helices in the 
asymmetric unit. These monomers are arranged into a set of four homotetramers. Two sets of 
these tetramers are arranged parallel to each other. Contact is observed between the C-terminal 
loop of one tetramer and the C-lobe helices of the adjacent tetramer. 
 How do EspB monomers interact with one another? 
 Every homo-tetramer has two monomers (monomers A and B and monomers C and D) 
that are arranged anti-parallel to each other creating an interacting interface and a central helix 
bundle. Contact is observed between the C-lobe helices of two monomers within the tetramer. 
For instance monomer A interacts with monomer D and monomer B interacts with C via the C-
lobe helices. The monomers have regions on the N- and C-terminus that lack electron density 
due to disorder and flexibility on these ends. 




 The three dimensional structure of a protein provides insights into its probable function. 
Therefore, proteins with similar functions often tend to adopt similar folds even when they have 
very low sequence similarity. The results obtained from the x-ray crystallography of EspB 
indicate novel functional roles for the secreted proteins Rv3881c (EspB). 
 The 3D fold structure of EspB292 shows a helix-turn-helix fold at the N-terminal of the 
protein and the C terminal end of EspB292 has a WEG tripeptide motif at the position 176–178 
that is similar to the WXG motif observed for the ESAT-6 like family of proteins. Based on 
previous results, the N-terminal region of Rv3879c displays helical regions followed by coiled-
coil regions, similar to fibrinogen fold. These observations suggest that the N-terminal regions of 
EspB and Rv3879c can form a four-helix-bundle similar to CFP-10/ESAT-6 pair.  
 Interestingly, the 3D fold analysis of EspC protein also adopts a similar fold to that of 
ESAT-6 and EspB and the N-terminal region of EspA exhibited WXG motif. With regards to the 
secretory proteins of the ESX-1 secretion pathway, the current analysis indicates that the 
secretory protein pairs have a preference to adopt a four-helix-bundle structure. While the CFP-
10/ESAT-6 and EspA/EspC pairs were previously reported to have such a structure, the present 
analysis suggests that the other secretory protein pairs EspB/Rv3879c may also adopt similar 
structures. 
 How does the structure provide insight into cellular environments that Mtb encounters?  
 Based on our chemical cross-linking experimental observations and mass spectrometric 
studies, as well as EspB structure, EspB292 proteins form complex assemblies only at high 
concentrations (>100 µM). Therefore, the cleaved EspB protein that is secreted into the 
extracellular milieu is capabale of forming higher order oligomeric states and therefore, forming 




 Since the truncation of C-terminus of EspB is necessary to regulate the secretion of 
virulence factors, the protein-protein tetramer network is probably competing with four-helix-
bundles for translocation (through the mycomembrane) using the same machinery. 
 In mycobacterium tuberculosis’ phagosomal lumen, iron plays a biphasic behavior. Its 
content first decreases up to four-fold within the first hours of infection, and increases from 5 to 
25 folds during the following 24 hours. By seting up experiments that would mimic the 
phagosomal environment, we studied how the virulence factors are affected at each condition. To 
determine the effect of metal ions concentration on the EspB292 oligomerization, we compared 
the aggregation level of protein in various amounts of different metals. EspB exists mainly in its 
monomeric form in presence of many ions including Na+, K+, Cl-, Ca2+, Mg2+, Po43-, So42- and 
Zn2+. However, our findings further suggest that the aggregation of EspB292 can be significantly 
influenced by the content of the iron, and copper ions in the environment  
 How does the structure of EspB predict the interaction with virulence factors? 
 Based on the crystal structure we can also observe that EspB can adopt a homodimer 
fold. The N terminal domain of EspB roughly resembles the helix-turn-helix domains of CFP10.  
The structure of EspB292, residues 135–226, is also roughly superimposable with the ESAT-6 
structure with residues 2–104. This region of ESAT-6 and EspB each has a WxG motif at the 
turn of the second helix-turn-helix subdomain. In EspB292, these two subdomains form an 
extensive interface of non-covalent interactions, and the linker connecting them adopts an 
extended conformation that anchors loosely to the helical bundle through van der Waals 
interactions. 
 Notably, EspB also shows domains and regions that is specific to itself and is not found 




‘‘helical tip’’ that is rich in solvent-exposed hydrophobic/aromatic/acidic residues. The tip ends 
in an extended polyproline stretch (residues 270–288) that sandwiches between the subdomains 
through hydrophobic interactions provided by prolines and aliphatic side chains.  
The EspB292 crystal structure also exhibit the unique relative disposition of multiple 
characteristic ESX sequence motifs, including a structured view of the helical export arm. In this 
work, we define the export arm to be residues 78–93 of EspB which is corresponding to the 
appendage that is dynamic in the structure. These residues from the export arm align on the same 
helical face upon binding the EccCb1 ATPase, targeting ESX secreted substrates for secretion. 
 How does the structural information predict the EspB membrane transport mechanism? 
 Previous studies have provided experimental evidences that Rv3868 interacts with CFP-
10/ESAT-6 and EspA/EspC pairs and helps in their multimerization. This multimeric protein 
assembly as well as EspB/Rv3879c is recognized by Rv3870 that is a member of Ftsk/SpoIIIE 
family of DNA translocase proteins. Rv3870 contains two transmembrane helices and a single 
FtsK ATPase domain and is known to interact with another cytoplasmic FtsK/SpoIIIE family 
protein Rv3871 that contains two FtsK ATPase domains. The α and β units of the FtsK domain 
containing proteins are known to multimerize to produce a hexameric ring with an inner diameter 
of 30Å. During cell division, this hexameric multimer acts as a DNA pump which translocates 
double stranded DNA with diameter of 20 Å. The α and β units domains of Rv3870/Rv3871 
pairs also forms a hexameric ring, similar to that formed by a hexamer of FtsK proteins. 
 Structural analysis of CFP-10/ESAT-6 four-helix-bundle diameter has previously shown 
to be approximately 20–23 Å. Our findings suggest that each EspB292 monomer is similarly 
alpha helical and is roughly shaped like a cylinder with 103.6 Å length and a diameter of 16.1 Å 




study suggest that, the FtsK family proteins (Rv3870 and Rv3871) recognize and translocate the 
four-helix substrates similar to that used by FtsK family proteins for the translocation of double 
stranded DNA. Therefore, the Rv3870/Rv3871 hexameric ring of T7SS may be a good example 
of machinery that has evolved from a specialized double stranded DNA translocator to a protein 
transporter.  
 The consecutive step after recognition of the secretory proteins by Rv3870/Rv3871 ring 
is translocation of these proteins through the inner membrane pore of Rv3877. The diameter of 
the inner pore considering a compact arrangement of the helices is determined to be 
approximately 26 Å or larger upon incorporating the side-chain lengths and interactions. Thus, 
this data also suggests that the substrate pairs (four-helix-bundles) of the ESX-1 secretion 
pathway would be able to fit into and be translocated along the inner pore of Rv3877. 
 7.2 Crystal Structure of Ct-Rio2 with AMP and ADP/Na2VO4 
 In chapters 4 and 5, the crystal structure of Ct-Rio2 was determined and the structures of 
AMP and ADP/VO4 bound Ct-Rio2 were compared.  
 The following questions are answered based on the information that was obtained 
through crystallographic structure. 
 What is the structure of Ct-Rio2 in presence of transition state analogs? 
 What is the function of catalytic loop in the active site of this protein? 
 What is the mechanism of the phosphoryl transfer from the ATP to the Asp residue? 
 In both of the structures of AMP- and ADP/VO4-bound Ct-Rio2, the Ct-Rio2 protein 
showed a bilobal structure that was expected. In the AMP bound protein the Asp257 bonded the 
α-phosphate of the AMP in a different location and orientation compared to that of the ADP 




 The movement of Asp257 in the transition state analog structure reveals that in the 
presence of the ATP the protein bilobal structure opens up to accommodate the ligand. The 
orientation of Asp257 is then changed to bind the gamma-phosphate of the ATP. In this case the 
vanadate structure mimics the γ-phosphate of the ATP. The structure of Ct-Rio2 in a complex 
with AMP aligns well with the previous apo protein structure. Moreover, Ct-Rio2 as expected 
showed an extended C-terminus containing αJ. The αJ interacts with the kinase domain through 
both hydrophobic and hydrophilic interactions with αC, αF, the flexible loop and the metal 
binding loop.  
 The Asp257 displays to both VO42- and Mg2+ through polar interactions. In the bilobal 
kinase domain of Ct-Rio2 at pH 5.4, AMP is bound with no trace of VO4 in its active site. The 
winged helix domain of the two structures is not completely superimposed. The overlay of the 
AMP region in the crystal structures of Ct-Rio2 bound to AMP and ADP at two different pH 
showed that both C and N terminal lobes were apart. The overlay of the active site of Ct-Rio2 
bound to ADP and Orthovanadate vs. Ct-Rio2 bound to AMP displays a dramatic movement of 
Asp257 from the AMP bound complex to the vanadate bound complex. 
 7.3 The Evolutionary Origins of the Eukaryotic Protein Kinases 
 Another ultimate goal from the structural study of Ct-Rio2 was to quire knowledge about 
evolutionary relationship between Rio kinases and the canonical eukaryotic protein kinases. 
Towards this goal, the focus of my research was to target the non-ribosomal protein, Ct-Rio2 by 
asking the following questions: 
 Can Rio2 act as the evolutionary origins of the eukaryotic protein kinases? 
 The procedure that was used for the purification of the mutants was at the pH of 5.4. We 




to AMP. But the comparison of the crystal structure of all of the mutants can be studied since all 
of them were attached to the same nucleotide. The overlay of the C-Terminal domain in the 
crystal structures of G228N and G228A of Ct-Rio2 exhibited that the winged regions were not 
superimposed perfectly and the presence of the Asn at the 228 opened up the phosphate binding 
loop. This could be the reason for the less ATPase activity of epks as compared to the Rio family 
of kinases.  
 The residues such as R, N and D are very similar in terms of charge and size to what we 
often observe in the eukaryotic protein kinases. But glycine and alanine that are found in Rio 
family of kinases close the catalytic loop and make the ATPase activity more preannounced. In 
contrast, the kinase activity seems to be less pronounced in the Rio family of the kinases. The 
epks perform kinase activity on the conserved serine residue much easier than Rio kinases. In 
fact, what we have observed so far suggest that Rio kinases are more of ATPases than kinases. 
Upon the overlay of the bound AMP groups none of the C and N terminal lobes neither the 
winged helix domain of the structures was completely superimposed. The overlay of the c-
terminal region in the crystal structures of G228N, G228A and G228 of Ct-Rio2 bound to AMP 
showed that while the A and wild type Glycine Ct-Rio2 were superimposable the Asn mutated 
Ct-Rio2 was structurally different.  
7.4 Future work 
 There are many interesting points yet to be answered about both of the EspB and Rio2 
proteins. Our crystal structure of EspB along with further biochemical studies has revealed that 
EspB tends to aggregate to higher order oligomers. It would be interesting to find out how this 
oligomerization affects the virulence of Mtb in vivo. Our experiments also suggest that EspB 




role in EspB binding to other proteins. This helical tip in PE.PPE class of proteins is known to 
bind a protein which is suggested to assist the proteins in secretion. We propose that EspB can be 
binding Rv3871 or Rv3879 genes. This is due to the experimental observation that shows in the 
absence if these to cytosolic proteins EspB are not capable of being transported to the 
extracellular milieu. This binding of these proteins to EspB can be studied both in vitro and in 
vivo followed by the structural study of EspB and Rv3871/79 proteins using crystallography. 
This piece of information can help us design therapeutics or drugs that would target the transport 
of EspB and hence affect the virulence by limiting the CFP-10 expressions as well as introducing 
defect in ESAT-6 and CFP-10 heterodimer secretion.  
In terms of the Rio2 proteins there are many questions and problems that are yet to be answered. 
Our interest lies primarily in understanding the mechanism of phosphoryl transfer from ATP to 
the Asp257. Along with the structural studies that are listed in this thesis, the Rio protein’s 
ATPase and phosphoryl release activity can be studied using kinetic analysis experiments. For 
example by enzyme coupled assays and stop flow experiment we can gain more specific insights 
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